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ABSTRACT 
Background 
Despite a high burden of disease, in many health districts in the Western Cape, 
South Africa, intimate partner violence is known to be poorly recognised and 
managed. To address this gap in service an innovative intersectoral model for the 
delivery of comprehensive intimate partner violence (IPV) care was piloted in the 
Witzenberg, a rural, agricultural sub-district known to have a high incidence of IPV. 
It was not known whether the initiative was a success from the perspective of the 
women using the service, from the service providers or from the managers.   
Methods  
A qualitative evaluation was conducted. Ten service users were interviewed to 
explore their experience of the intervention. Two focus groups were conducted 
amongst health care workers, and one focus group and six interviews were 
conducted with the intersectoral implementation team, to understand their 
experience of implementing the intervention. Documents relating to the pilot were 
also analysed. A contextualized thematic content analysis approach was used, 
triangulating the various sources of data, and utilising inductive as well as deductive 
approaches.     
Results 
Over the pilot period 75 women received the intervention. Study participants 
described their experience of it as overwhelmingly positive, with some experiencing 
improvements in their home lives. Significant access barriers included unaffordable 
indirect costs, fear of loss of confidentiality, and fear of children being removed 
from the home. For health care workers, barriers to inquiry about intimate partner 
violence included its normalisation in this community, poor understanding of the 
complexities of living with violence and frustration in managing a difficult emotional 
problem. Health system constraints impacted on the pilot, affecting continuity of 
care, privacy and integration of the intervention into routine functioning, and the 
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process of intersectoral action was hindered by the formation of alliances. 
Contextual factors, for example high levels of alcohol misuse and socioeconomic 
disempowerment highlighted the need for a multifaceted approach to addressing 
intimate partner violence.  
Conclusion  
The results of this qualitative evaluation draw attention to the need to take a health 
systems approach and focus on contextual factors when implementing complex 
interventions. They will be used to inform decisions about instituting appropriate 
intimate partner violence care in the rest of the province. Additionally, there is a 
pressing need for clear policies and guidelines framing intimate partner violence as 
a health issue.    
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Introduction 
Background 
Intimate Partner Violence in South Africa 
Interpersonal violence is the second highest contributor to years of life lost in South 
Africa. Of this very high burden, in women, intimate partner violence (IPV) accounts 
for 62.4% [1]. The rate of intimate femicide in South Africa has been found to be 8.8 
in 100 000, the highest rate reported worldwide [2]. 
For women suffering intimate partner violence the negative effects span all aspects 
of health, from direct mortality to increased risk factors for poor health outcomes. 
Besides direct mortality from injuries, there is the potential for IPV to lead to 
mortality through suicide [3], maternal causes [4] and an association with HIV [5]. 
Increased morbidity is even wider-spread, stemming from increased mental, 
physical (including injuries) and reproductive health problems. 
Mental health problems that are more prevalent among women who have 
experienced IPV include depression, post-traumatic stress disorder, suicidality and 
alcohol and substance abuse [6]. 
Women who have experienced IPV are more likely to report poor overall health and 
more likely to suffer physical symptoms including pain [3]. They are also more likely 
to have gastrointestinal symptoms and diagnosed functional gastrointestinal 
disorders, gynaecological disorders, and many more physical disorders [7]. 
There is also a higher risk of being HIV positive for victims of IPV, even after 
adjusting for risk-taking behaviours [5]. This could be due to male perpetrators 
being more likely to engage in risky behaviours outside of the relationship and 
therefore being more likely to transmit HIV [8]. Women who are in controlling or 
abusive relationships are also less able to negotiate condom use. Risky behaviours 
associated with IPV include multiple partners, transactional sex and substance 
abuse [5].   
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Pregnancy-related problems include associations between IPV and poor maternal 
and foetal health outcomes. Poor maternal health outcomes include increased 
sexually transmitted infections, vaginal bleeding and premature rupture of 
membranes. Poor foetal outcomes include low birth weight and preterm delivery 
[4]. There is also evidence that IPV is linked to unintended pregnancy [9]. 
Despite seldom seeking help from available services [10], women who have a 
history of IPV have been shown to have significantly higher levels of healthcare 
utilization [11]. This suggests that the health services are an important opportunity 
to identify and intervene in IPV. 
IPV interventions 
The high burden of IPV and its many health-related effects place IPV as a major 
public health issue. Despite this, there is a relative lack of evidence-based 
interventions for the detection and management of IPV, particularly in the primary 
care setting [10,12]. 
In general, at primary care level management consists of screening and referral to 
specialized services. How effective screening is in improving outcomes depends on 
the intervention offered after referral. At the time of a review published in 2003 
[12], no studies that met inclusion criteria had evaluated interventions in the 
primary care setting.  More recently, a randomized control trial conducted in urban 
primary care clinics in the United States of America [13] assigned women to either a 
simple assessment followed by referral or a simple assessment followed by nurse 
case management, and found that both groups had decreased self- reported levels 
of threats of abuse and assaults. 
Current evidence points to comprehensive health system approaches that 
incorporate intersectoral action being more effective. A recent review suggests that 
creating a supportive environment for the intervention, as opposed to focusing only 
on changing the way individual providers behave is key to such an approach [10].    
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This is supported by other evidence, with another review finding that interventions 
with institutional support, effective protocols, thorough ongoing training and 
immediate access or referrals to services tended to have better outcomes [14].   
Colombini [15] offers a framework for integration of IPV services into the health 
system. Three levels of integration are outlined, selective integration at a provider 
or facility level, comprehensive integration at a provider or facility level, and 
systems-level integration. Challenges to integration exist at the provider, facility and 
systems level. The project being evaluated here is an attempt to integrate an 
intervention into the district health system of the Western Cape, and could be 
described as systems-level integration because some services are offered at primary 
care level facilities, with referral to other resources at different sites. It is noted in 
this review that most interventions did not evaluate the processes of integration 
[15]. 
The intervention piloted in the Witzenberg 
From April 2012 an intimate partner violence intervention was piloted in the health 
services of the Witzenberg sub-district of the Western Cape. The pilot is a 
collaboration between the Western Cape Government Department of Health and 
Department of Social Development, and is provided from within the health services.   
The health services in the sub-district consist of a district level hospital, nine fixed 
primary care facilities, mobile facilities each attached to a fixed facility and home-
based services. Patients identified from any of these sources are offered the service, 
as described below, in one of the fixed primary care facilities. Thus, a health care 
professional in this model refers to any doctor or nurse working in the health 
services of the sub-district, and women may be identified for the service by any 
health care professional or community-based worker. The intervention was 
developed by Dr. Kate Joyner based on her prior research into IPV in the Western 
Cape primary care health services [16].   
It consists of a three-tiered model, represented below. 
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Figure 1: Three tier model for IPV intervention 
 
1st tier: Case-finding 
The first tier is provided by health care professionals and consists of identifying 
women experiencing IPV who are attending health facilities. A selective screening 
approach is used, where only women with specific cues or who are suspected of 
experiencing IPV are asked about it. When a cue is identified, a question is asked by 
the provider: “Are you unhappy in your relationship?” Following the answer to this 
question, a history of IPV is confirmed. 
Appropriate clinical care is then provided. This includes treatment of injuries, 
forensic documentation (J88 form, or appropriate documentation in the medical 
record), identification and treatment of sexually transmitted infections, offer of 
pregnancy test or family planning as appropriate, and offer of HIV testing. 
Training for this tier consisted of a two hour session that covered general issues 
about IPV as well as the appropriate management of IPV. A flow chart was provided 
with suggested cues and steps in management. All health care professionals in the 
relevant facilities were invited to attend the training sessions. 61 attended (52 
nurses and 9 doctors), 23 from the district hospital and 38 from primary care 
facilities, each facility having at least one health care professional that was trained. 
The next step is for the health care professional to offer referral to the IPV service. 
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2nd tier: Assessment and intervention 
The second tier of the intervention is provided by a social worker employed by the 
Department of Social Development. A protocol is used to conduct a comprehensive 
assessment and provide psychosocial care. An appropriate management plan is 
devised, including referrals where necessary. Referral resources include legal 
support and mental health services. The interaction should be patient-centred with 
a guiding style. 
The protocol includes: a full history of abuse and previous attempts to access help, a 
danger assessment and development of a safety plan, case-finding for mental 
disorders including screening for alcohol abuse, counselling and referral to 
appropriate resources. 
2nd tier: Empowerment group 
Following this assessment and intervention session, women may attend an 
empowerment group facilitated by the same social worker. A personal 
empowerment process was developed by the Department of Health for use in 
chronic diseases, but covers issues relevant to motivation and lifestyle change. A 
flipchart is used to cover five group sessions. 
3rd tier: community-based support groups 
Women will then be able to attend community-based support groups should they 
wish to. These groups have the potential to provide social support for women who 
feel very isolated, and ensure continuity in the community. It is envisioned that the 
IPV survivors may be able to facilitate the support groups as they build their own 
capacity to do so. At this time support groups have not yet been set up in the 
Witzenberg and this tier will only be implemented in future phases of the project. 
The third tier will thus not be evaluated here.    
Operational Management Team 
As part of the monitoring of the project, an operational management team meets 
monthly to discuss progress and challenges. This team consists of members from 
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the Department of Health at district and provincial level as well as the Department 
of Social Development, the South African Police Service and the University of 
Stellenbosch. The University of Stellenbosch provide technical support and training 
through Dr. Kate Joyner and Prof Bob Mash who also developed the model. 
Intersectoral action 
The WHO defines intersectoral action for health as follows: a recognised 
relationship between part or parts of the health sector with part or parts of another 
sector which has been formed to take action on an issue to achieve health 
outcomes (or intermediate health outcomes) in a way that is more effective, 
efficient or sustainable than could be achieved by the health sector acting alone 
[17]. 
Recently, increased recognition of the underlying social determinants of health and 
the need for multiple sectors to play a role in addressing these determinants, has 
led to increased interest in how intersectoral action for health can be achieved.    
A recent scoping review found that 43 countries have initiated government-led 
intersectoral action for health equity since 1987, the majority in the last ten years 
[18]. The review concluded that in general improved descriptions of the processes 
of intersectoral action would be useful. 
Many factors enabling and preventing success of intersectoral action have been 
described [19,20,21] and can be used as a framework for discussing implementation 
of intersectoral action, bearing in mind the importance of the context of the 
intervention.     
Evaluating implementation 
Assessing implementation is necessary to determine to what extent outcomes may 
be due to an intervention [22]. In a review of how implementation affects 
prevention and promotion programme outcomes and what factors affect 
implementation, Durlak and DuPre [22] concluded that there is evidence that more 
effective implementation is associated with improved outcomes. They reviewed 81 
studies of prevention and promotion programmes related to child and adolescent 
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health in multiple settings to determine whether certain factors were associated 
with effective implementation, and used an ecological framework to categorise 
these factors. A framework that groups factors into community level factors, 
provider characteristics, characteristics of the innovation, delivery system factors, 
and support system factors was devised. This framework can be used to assist 
assessment of the implementation process. 
Statement of Research Question 
This research will investigate patients’ experiences of the intervention, as well as 
the service providers’ experiences of its implementation, to answer the question of 
how a model for intervening in IPV can be implemented in the district health system 
of the Western Cape. 
Purpose 
The results of this evaluation can be used to make recommendations to guide the 
implementation of this and similar interventions on a wider scale. 
Aim 
To evaluate the implementation of an intimate partner violence intervention in the 
district health system of the Western Cape and explore provider and user 
perspectives and experiences of this implementation. 
Objectives 
1) To describe the implementation process of the IPV programme into 
the routine functioning of health services in the sub-district. 
2) To describe the experiences of managers and service providers from 
the Department of Health and the Department of Social Development in 
implementing an IPV intervention in the district health system. 
3) To describe the managers’ and service providers’ motivations in 
implementing the project. 
4) To investigate managers’ and service providers’ perceptions of the 
value of the project. 
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5) To investigate managers’ and service providers’ perceptions of their 
roles and the role of the health services in intervening in IPV. 
6) To describe the processes of intersectoral collaboration within the 
intervention and the experiences of managers and service providers with 
these processes. 
7) To understand how patients have experienced the intervention and 
which aspects of the intervention patients have found to be beneficial or 
not. 
Research Design 
This evaluation will be undertaken using qualitative methods, combining focus 
groups, depth interviews and document review. It will be supported by data 
gathered in the process of monitoring the pilot. This will include attendance data, 
appointment books and registers of women offered the service at individual service 
points. 
Interviews 
Two categories of depth interviews are planned- interviews with service users in 
order to explore in-depth their experiences of the intervention, and interviews with 
key informants involved in providing the intervention, in order to explore their 
experiences of the implementation process. 
Service users will only be interviewed individually because of the sensitive and 
confidential nature of the topics under discussion. 
Service users 
Service users will be purposively selected to participate based on their interactions 
with providers. Women who have participated in the intervention and are likely to 
be forthcoming about their experience will be invited to participate. Due to the 
limited resources available to this study, the aim will be to sample between five and 
ten patients from at least three service points. 
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They will be accessed by asking the social worker providing the intervention to 
identify women who would likely be willing to participate, and ask them whether 
they would be willing to be contacted by the researcher. They will be asked only 
after the intervention has been provided, to ensure that patients are very clear that 
there will be no negative effects should they choose not to participate. 
An attempt will also be made to access women who have been identified as 
experiencing IPV by health care professionals and have declined to participate in the 
intervention. This could provide valuable information about gaps in service delivery 
and access issues, as well as other barriers to the uptake of the intervention 
amongst women using health services. 
The attempt to access these women will be made through a community contact 
that is aware of several such women in her community and has agreed to find out if 
they would be willing to participate in this research. The researcher will only 
approach women who have indicated that they would be willing to be involved, and 
participation will be completely voluntary. The importance of strict confidentiality 
will be emphasised during the process of accessing participants. The aim will be a 
sample of at least three women. 
Service providers    
Key informants who will be invited to participate include: 
 The social worker providing the second tier of the intervention 
 A manger from the Department of Social Development 
 A Department of Health district manager who was the driver for this 
project in the health services 
 The psychologist and mental health nurse of the sub-district who are 
on the operational management team 
 A member of the South African Police Service who is on the 
operational management team 
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A social worker employed by the Department of Social Development provided the 
second tier of the intervention, and as such was largely at the forefront of service 
provision. Her experiences of providing the intervention and of working within the 
health services will be of value in exploring both the provision of this tier of the 
service as well as the health system processes from another perspective. 
A manager from the Department of Social Development will also be interviewed. 
This is the direct supervisor of the social worker providing the second tier, who was 
also on the operational management team.      
One Department of Health district manager will be invited to participate as a key 
informant, the driver of this project within the health services.   
The psychologist and mental health nurse in the sub-district will also be invited to 
participate, as they have both provided support to the social worker and were on 
the operational management team. They have insight into the intervention, as well 
as being key in the provision of services to women experiencing IPV before and 
during the pilot. They were also engaged during the pilot to provide extra support 
to the social worker where needed. 
Similarly, a member of the South African Police Service who was part of the 
operational management team will be invited to participate. He is also active in 
managing IPV within the police services. 
Focus groups 
Focus groups will be conducted only with service providers. They will aim to develop 
an understanding of the organisational and cultural norms within the health 
services, and how these norms affected the implementation of this project. They 
will consist of eight to ten members each.   
Three focus groups are planned: 
 Managers at the district level of the health services 
 Service providers in primary care facilities 
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 Service providers at the district level hospital of the sub-district    
The group of managers will consist of all managers at the district level who have 
been involved in the project and are willing to participate. This will include all the 
remaining members of the operational management team. The inclusion of 
different levels of management may impair open sharing of experiences, and so the 
driver of the project who is on a higher management level will be interviewed 
separately.   
The groups of service providers will be chosen from primary care providers working 
in the Witzenberg and those working at the district hospital. The participants will be 
chosen strategically to consist of those with a range of responses to the project 
judging by the number of their referrals into the second tier of the intervention. 
Of the primary care providers, a range from different clinics will be sought, including 
clinics closer to and more remote from the town of Ceres. 
The choice to hold separate groups for different levels of care is an attempt to 
better understand the different roles and challenges each level of care within the 
district health system has experienced in implementing this intervention. 
A summary of the interviews and focus group participants is represented in Table 1 
below: 
 
 
 
 
 
 
 
 
  15 
 
 
 Interviews 
 
Focus groups 
Clients 5-10 Received service 
 
 
 3 Declined to utilise service  
(if possible) 
 
   
Managers DSD manager 1 District level managers 
 
 SAPS representative 
 
 
 District manager driving project 
 
 
   
Providers Social worker 
  
1 District hospital 
 Psychologist 
 
1 Primary care facilities 
 Mental health nurse 
 
 
Table 1: Interview and focus group participants 
Documents 
Documents pertaining to the intervention, for example meeting minutes and service 
level agreements, will be used to develop an understanding of the processes 
involved in the setting up of the project teams and implementing the intervention. 
Field notes kept by the researcher throughout the pilot will be also be drawn on and 
analysed. 
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Instruments 
The Researcher     
The researcher is a public health registrar placed in the Health Impact Assessment 
Directorate of the Western Cape Government Department of Health (provincial 
office), and as such was assigned to monitor and evaluate the pilot project for the 
Department of Health. This meant involvement in parts of the training and being on 
the operational management team. Role players within this project are all aware of 
this function. 
This may be significant to how the key informants relate to the researcher in that 
there may be some reluctance to admit to negative attitudes toward the project. 
Every effort will be made to impress upon them that their experiences and 
perceptions may be useful in improving the service.         
Discussion Schedule 
Five discussion schedules will be used. For service providers and managers there are 
three: one for the managers’ focus group and a slightly modified version for 
mangers interviews, and one for the providers’ focus groups. For users, there is a 
schedule for those who have been through the service and a modified schedule for 
those who have not. 
Discussion schedules were developed to meet the study objectives.  Appropriate 
prompts are provided for most questions. For the managers, questions cover roles 
in the project, experiences of the project, challenges, perceived usefulness of the 
project, integration into the health system, team functioning and role of the health 
system in IPV.   
Questions for providers cover experiences of the intervention, challenges, perceived 
value of the intervention, integration, self-efficacy, training and role of the health 
services in IPV. 
User schedules cover expectations, benefits and harms of the service, possible 
improvements, appropriateness of the setting, and appropriateness of screening. 
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For those who have not been through the service, questions cover reasons for not 
accessing the service, expectations and potential improvements.   
Analysis 
Analysis will be contextualised interpretive content analysis. 
Interviews and focus groups will be audio- recorded and transcribed, with 
simultaneous translation into English where necessary. Interviews will be conducted 
largely in English, using Afrikaans where the participant is uncomfortable in English. 
The interviews will all be conducted by the researcher, who will also conduct the 
analysis. Transcripts will be checked for accuracy by the interviewer.    
An initial reading of the transcripts will be used to check for accuracy and to 
become familiar with the material, following which a further reading will be used to 
draw themes inductively from the data.  Coding will then be undertaken using these 
themes. Field notes and documents (where appropriate) will be analysed in the 
same way as transcripts. Where documents are not appropriate for content analysis 
because of their superficial nature, they will be used to enrich understanding of the 
background and set-up of the project. Atlas-ti 6 (Scientific Software Development, 
2011) will be used to manage data. 
Ethics 
Confidentiality 
Confidentiality will be maintained by having no personal identifiers on the interview 
or focus group transcripts or notes, and using codes to refer to interviews and focus 
group participants at all times. Audio files and electronic transcripts will be 
password protected, and any original or printed material will be kept in a locked 
cupboard. In reporting, no reference to any characteristics likely to lead to 
identification of the participants will be made, except where this has been 
specifically consented to (with regard to service users absolute confidentiality will 
be maintained throughout). 
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Informed consent 
Written informed consent will be obtained using the forms attached. This will 
include separate consent to audio recording. All relevant information regarding the 
study will be given, and the voluntary nature of participation stressed. Participants 
will be advised that they may discontinue the interview at any time with no 
negative consequences. This will be emphasised, as those participants who are 
employees of the Department of Health may feel that participating is expected of 
them as part of their work, and patients must be made aware that their access to 
services will in no way be hampered if they choose not to participate or to 
withdraw. 
Although every effort to avoid this will be made, certain key informants (for 
example the social worker delivering the intervention) may be identifiable in 
reporting because of their unique roles. For this reason, a separate consent will be 
obtained from them. This will specify that although they will not be named, there 
may be the possibility that those closely aligned with the project would be able to 
identify them. This will be avoided wherever possible.  
Non-maleficence 
It is unlikely there will be any negative consequences to participants who are service 
providers. In the event that an emotional response is evoked to the extent that 
participants may need counselling, resources will be made available to them 
(through resources available to the project). 
Service users who are interviewed will already have been referred to appropriate 
resources as part of the intervention. It is unlikely that any severe negative emotion 
will arise in the interview that has not already come up during the intervention. 
However, should anything occur to occasion concern that additional counselling or 
referral might be required, the resources available to the intervention will be 
offered. 
Women who have not participated in the intervention prior to being interviewed 
have a potentially greater risk of harm from participating in this research. All of 
these women will be offered referral to the service following their interviews, or to 
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any appropriate services necessary, for example counselling or legal assistance. 
These resources are already in place as part of the intervention. Strict 
confidentiality will be maintained. Women will be interviewed at health facilities, 
and will be given a sick certificate for that day. All appointments and communication 
will refer to women’s health and not to domestic violence or IPV. 
Justice 
The purpose of this research is to contribute to improving the management of IPV 
by contributing to the design of interventions that are implementable in the district 
health services. Although this would not directly benefit the participants, it could 
help to ensure their perspectives and needs are taken into account in the future. 
Every attempt will be made to ensure validity in the analysis and reporting of 
results.         
Logistics 
Timeline 
Data collection will occur in March 2013, in line with the end of the 12 month pilot 
project. The aim is to complete the write up by March 2014. 
Budget 
Item Cost 
Transcription R500×17=R8500 
Accommodation in Ceres R350×4=R1400 
Stationery Costs covered 
Total R9900 
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Objectives 
This literature review aims to contextualise the protocol titled: Evaluating the 
implementation of an intervention for intimate partner violence in the district health 
system of the Western Cape. 
The objectives were to review key publications regarding the following, with a more 
comprehensive focus on the South African context: 
1. Burden and health effects of intimate partner violence 
2. Health sector based interventions for intimate partner violence 
3. The integration of intimate partner violence interventions into health sys-
tems  
4. Service user and health care worker perspectives on intimate partner vio-
lence care  
Search Strategy 
Multiple searches were conducted between August 2012 and January 2014, using 
PubMed, CINAHL and PsycINFO. All types of study design were included. Keywords 
included intimate partner violence; domestic abuse; violence against women; 
gender based violence; South Africa; developing countries; intervention; health 
systems; health care worker; health care provider.  
Summary of the literature 
Although this review focused on the South African context, relevant international 
literature is included. Of note is a remarkable convergence between studies 
conducted in South Africa and in many other settings.   
Definitions 
There are several terms used to describe various forms of violence against women. 
Intimate partner violence (IPV) refers to “behaviour by an intimate partner that 
causes physical, sexual or psychological harm, including acts of physical aggression, 
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sexual coercion, psychological abuse and controlling behaviours” *1+. Gender based 
violence refers more broadly to any act of violence committed against a person 
because of their gender, and includes intimate partner violence and sexual violence. 
Domestic violence is also an umbrella term, defined broadly in the Domestic 
Violence Act (No 116 of 1998) [2] to include physical, sexual and emotional abuse, 
harassment and stalking, damage to property and other controlling or abusive 
behaviours, within any domestic relationship.  
 The Act makes provision for women to obtain protection orders against their 
partners, imposes a legal obligation on police officers and clerks to inform women 
of their rights, and allows police to arrest abusers without a warrant and seize their 
weapons [2].    
Burden of Disease 
The WHO estimates that 30% of women globally who have been in a relationship 
have experienced physical or sexual intimate partner violence [3]. In the WHO Africa 
region, this estimate is as high as 36.6% (95% CI 32.7; 40.5%) [3]. These figures do 
not include emotional violence which is often omitted from prevalence studies, 
although it appears to be common and have serious mental health implications [4]. 
In South Africa, interpersonal violence is the second highest contributor to years of 
life lost [5], and in women, intimate partner violence (IPV) accounts for 62.4% of 
this high burden [5]. A survey of women in three South African provinces found 
lifetime levels of physical abuse of between 19 and 28% [6], and in Cape Town 
42.3% of working men interviewed reported perpetrating physical violence in a 
relationship in the previous ten years [7]. 
Health effects 
For women experiencing intimate partner violence the negative effects span all 
aspects of health, and can lead to mortality, morbidity and increased risk factors for 
poor health outcomes. These effects are mediated through multiple pathways, 
including physical trauma, psychological trauma and stress, and controlling 
behaviours leading to limited reproductive control and lack of autonomy in health 
care seeking [3]. 
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Mortality can be caused through homicide, or indirectly through suicide [8], 
maternal causes [9] and an association with HIV [9]. Increased morbidity results 
from increased mental disorders, injuries, increased chronic conditions and physical 
complaints and reproductive health problems, including sexually transmitted 
infections and HIV [3,8,11]. 
Mental disorders that are more prevalent among women who have experienced IPV 
include depression, post-traumatic stress disorder, suicidality and alcohol and 
substance abuse [12]. A recent study in South Africa found that of women who 
obtained protection orders against intimate partners, 66.4% experienced severe 
depression symptoms, and 51.9% experienced severe post-traumatic stress disorder 
symptoms [13]. A recent systematic review of longitudinal studies was able to 
conclude that IPV is associated with incident depression symptoms, adding to 
evidence of a causal relationship [14]. 
Women who have experienced IPV are more likely to report poor overall health and 
more likely to suffer physical symptoms including pain [8]. They are also more likely 
to have gastrointestinal symptoms and diagnosed functional gastrointestinal 
disorders, gynaecological disorders, and many more physical disorders [11]. 
IPV is associated with an increased risk of being HIV positive, even after adjusting 
for risk-taking behaviours [10]. Besides the biological risk due to forced sex, male 
perpetrators are more likely to engage in risky behaviours outside of the 
relationship and are therefore more likely to transmit HIV [15]. Women who are in 
controlling or abusive relationships are also less able to negotiate condom use [3]. 
Risky behaviours associated with IPV include multiple partners, transactional sex 
and substance abuse [10].  
Pregnancy outcomes are worse for women experiencing IPV, in terms of both 
maternal and foetal health. Poor maternal health outcomes include increased 
sexually transmitted infections, vaginal bleeding and premature rupture of 
membranes. Poor foetal outcomes include low birth weight and preterm delivery 
[9]. There is also evidence that IPV is linked to unintended pregnancy [16]. 
Women who have a history of IPV have been shown to have significantly higher 
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levels of healthcare utilisation [17] and the estimated economic burden is significant 
[18].  
The high global burden of IPV, its numerous health effects, its impact on efforts to 
prevent HIV and the opportunity afforded to health care providers to inquire about 
violence, have contributed to growing recognition that IPV is an issue of major 
public health concern.  
Conceptualising IPV 
Many theoretical perspectives and frameworks have been used to explain and guide 
research on IPV. For example, the feminist perspective highlights patriarchy and 
male dominance as causes of IPV, while the sociological perspective points to prior 
experiences of violence and unequal resources in relationships [19]. An ecological 
framework approach attempts to pull together factors that lead to violence on 
multiple levels, incorporating individual, relationship, societal and structural causes 
[20]. No one theory fully explains IPV, and causes are complex and interrelated, with 
dynamic, non-linear pathways [21].   
A theoretical model developed by Jewkes [21] describes two community-level 
factors that operate as necessary causes of IPV. These are gender inequality, or male 
superiority, and social acceptance of the use of violence to resolve conflict. Both are 
prevalent features of South African communities [21]. 
Poverty interacts with these factors by hampering the ability of women to leave 
violent relationships, and potentially leading men who are disempowered 
economically to gain power by exerting dominance over women [22]. Masculine 
identity is a possible mediator in the relationship between poverty and IPV, with 
men living in poverty unable to fulfil their conceptualisation of masculinity, leading 
to violence [21]. 
On a relationship level, the existence of conflict and negative styles of conflict-
management, and on an individual level, alcohol abuse, are important contributors 
to IPV. Relationship conflict has been hypothesised to be a mediator in the 
relationship between both poverty [21] and alcohol [22] and IPV, with conflict 
arising around household finances or either partner’s drinking leading to violence. 
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Conflict that is most likely to lead to IPV is related to women contravening accepted 
gender roles. In South Africa, this often translates to women having multiple 
partners, women drinking alcohol or conflict about male drinking [21]. 
Often IPV is conceptualised as a single phenomenon, but theoretical and empirical 
work [23,24] has described subtypes that assist in expanding on the psychosocial 
effects of IPV, and in highlighting gender inequities relating to the experience of 
violence. Johnson’s [23] typology describes four forms of IPV: intimate terrorism, 
violent resistance, mutual violent control, and situational couple violence, with 
differing dynamics and degrees of coercive control. Situational couple violence does 
not involve attempts to gain control, whereas intimate terrorism refers to the 
ongoing use of violence to exert control. Violent resistance is a response to a 
partner’s attempts to exert control, and mutual violent control is violence used by 
both partners to control each other.   
There is evidence that a life course perspective could be useful both in 
understanding IPV risk, and in developing prevention programmes. Experiences in 
childhood and early adulthood, such as childhood abuse, earlier age at first sex or 
forced first sex, have been shown to increase IPV risk in women [25,26]. The WHO 
multi-country study on women’s health and domestic violence found that risk was 
highest when both the woman and her partner experienced a risk factor [25], 
highlighting the importance of prevention approaches that target both men and 
women. In addition, empirical evidence has demonstrated that cumulative violence, 
and violence experienced in multiple domains over the life course, has negative 
effects on health and psychosocial development [27,28].   
The Response of the Health Sector to IPV 
Despite growing recognition that IPV is an important public health issue, there has 
been a relative lack of evidence regarding the most effective health system 
responses [29,30,31]. A  Cochrane review of IPV interventions concluded that there 
is insufficient evidence to show whether current health sector- based approaches 
are effective in reducing violence or improving psychological well-being [31]. This 
points to a need for the development of new health sector responses [32], as well 
as more rigorous evaluations of interventions and their integration into health 
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systems, particularly in primary care, which is relatively under-represented in the 
literature [30,33].  
There is, however, sufficient evidence that intervening for IPV in a primary care 
setting can be beneficial. A recent systematic review of interventions based in 
primary care found that 76% of 17 included studies showed an improvement in at 
least one measured outcome, including reductions in IPV, improvement in health-
related quality of life and increased safety promoting behaviours [34]. Included 
studies were largely of United States origin, with only one study originating in South 
Africa, one in Peru and one in Hong Kong.  
In addition, the WHO has recently published clinical and policy guidelines for 
responding to IPV and sexual violence [1], synthesising the best available evidence 
in an attempt to increase the prominence of IPV as a health concern amongst policy 
makers and health care providers.  
On a policy level, the guidelines recommend integrating services into existing 
structures as far as possible, as well as having multiple models of care appropriate 
for different levels, but prioritising primary care [1]. These recommendations are all 
based on very low quality evidence, reflecting the relative lack of quality evaluations 
of health system responses. The guideline outlines minimum requirements for an 
appropriate health sector response, including having clear local policies and 
protocols, ensuring supportive management including financial resources, providing 
comprehensive care as well as resource materials, working intersectorally, 
appropriate monitoring and evaluation, and providing support for carers [1].  
Screening and intervening  
In primary care, intervention for IPV usually consists of screening or identification of 
women experiencing IPV, followed either by on-site intervention or referral to 
further specialised services [34]. Universal screening for IPV is controversial, 
although the need to identify cases non-routinely in health care settings is widely 
accepted [35]. The U.S. Preventive Services Task Force, since 2013, has 
recommended universal screening for IPV in women of childbearing age [36]. 
However, a more recently published, well-conducted randomised controlled trial 
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(the WEAVE study) found no difference in primary outcomes between women who 
were routinely screened for violence and a control group [37]. This trial, in addition 
to prior evidence [38,39], has led to the expert conclusion that universal screening 
for IPV is ineffective in improving health [32]. Although screening is able to identify 
women experiencing IPV, uptake of interventions is impeded by numerous barriers 
and is often low, and in the setting of asymptomatic women, current intervention 
approaches have not been shown to be of benefit.   
Inquiring about and discussing violence in specific cases during health care 
encounters (selective screening or case-finding) has been recommended as an 
alternative approach [32,40], followed by more complex, individualized 
interventions [32]. This approach has been demonstrated to be feasible, with a 
cluster randomised controlled trial showing training and support can significantly 
increase the number of women identified and referred to services in the absence of 
universal screening [41].    
Several trials of IPV interventions in primary care have recently taken place, most of 
them in developed countries, utilising doctors, nurses and lay providers to deliver 
interventions either on or off-site [37,38, 41,42]. These interventions commonly use 
empathic approaches and attempt to empower women by helping them to 
understand their situation, improve their safety and access community resources 
[34].  
One randomised controlled trial with two levels of intervention (a referral resource 
card and a protocol administered by a nurse) found both intervention groups to 
experience significant decreases in violence, suggesting that even the act of 
disclosure may be an important driver of change for women experiencing IPV [42].  
System level interventions  
Reviews of IPV interventions have emphasised that comprehensive, system-wide 
approaches have been the most effective [29,43,44]. IPV interventions are complex, 
and therefore require more than health care provider training to enable effective 
programme functioning within a health system. For example, a realist review 
(focusing on programme mechanisms to understand how and why programmes 
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work) found that providers can be supported by four elements of an IPV 
programme: institutional support at high levels, effective protocols, ongoing training 
and immediate access to support services [43].  
Colombini [45] has suggested a framework for the integration of IPV services into 
health systems. Three levels of integration are outlined: selective integration at 
provider or facility level, comprehensive integration at provider or facility level, and 
systems-level integration. Challenges to integration exist at all three levels. System 
level barriers include the lack of effective referral systems, lack of privacy, high staff 
turnover and insufficient coordination between multiple stakeholders [45]. These 
system level barriers need to be addressed to ensure effective intervention. 
A framework developed by Atun et al. [46] facilitates analysis of the integration of 
interventions into health systems functions. Five key components are identified that 
interact to affect the adoption of interventions. The components are the type of 
problem targeted, the intervention itself, the adoption system, made up of multiple 
interconnected actors and their context, health system characteristics and the 
broader environmental context. IPV interventions would be viewed as complex, 
because high user and stakeholder engagement are required, and interventions 
attempt to change behaviour [46].  
The evidence base informing the scale up of IPV interventions and their integration 
into health systems is lacking [47]. However, examples of published investigations 
that do exist provide lessons of interest to those wishing to institute an appropriate 
response to IPV. In Malaysia, the national scale up of One Stop Crisis Centres, an 
integrated health sector response to IPV, was investigated. Factors relating to health 
system structure and organisation, as well as external policy constraints were found 
to be barriers to implementation [47]. Several system level factors arising from this 
case study could be applicable in other contexts. Commitment at policy level was 
found to be necessary, which could be communicated to service delivery level by 
incorporating appropriate indicators into routine reporting. Adequate training as 
well as adjustments to service delivery, to ensure providers have the necessary time 
and privacy available to them, were required. Finally, flexibility of the model was 
important to allow its implementation at different levels of care.  
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An investigation of the integration of gender-based violence laws into the regional 
health systems of Spain found institutionalisation to be a challenge [48]. 
Advancements were often made through the actions of highly motivated 
individuals, raising concerns about sustainability. Budget allocation was found to be 
a key component of institutionalising change. It is also noted that since IPV is 
complex to respond to, protocols, while necessary, were insufficient and need to be 
supported by adequate training [48]. 
In South Africa, Vezimfilho, a model health sector response to IPV, was developed 
and implemented in four districts [49]. Important findings from an evaluation of the 
implementation process included the need for a systemic response, with political 
commitment, policies, protocols and effective referral systems being essential [49]. 
In addition, capacity building needed to include addressing values and attitudes 
towards IPV and gender norms, as well as interpersonal skills in health care 
providers. Support from managers in the health system and strong relationships 
between multiple stakeholders were seen as key to a sustainable approach [44]. 
System barriers to implementation included insufficient staff and lack of confidence 
in managerial support, while on a societal level providers’ attitudes and perceptions 
relating to gender hampered implementation [49]. The social barriers relating to 
gender imply that a comprehensive health sector response requires advocating for 
wider social change. 
Primary prevention  
Primary prevention of IPV remains a challenge. Two programmes have been tested 
in South Africa, attempting to address both IPV and HIV by focusing on the 
gendered nature of these interlinked epidemics.   
The Intervention with Microfinance for AIDS and Gender Equity (IMAGE) study 
implemented a microfinance intervention combined with participatory training that 
focused on gender and HIV, and encouraged community mobilisation. After 2 years, 
women enrolled in the intervention group experienced 55% less IPV in the previous 
twelve months, compared to the control group (risk ratio 0.45, 95% CI 0.23;0.91) 
[50]. Although it was unable to show a difference in HIV incidence in communities, 
the trial showed that a structural intervention that empowers households 
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economically can decrease violence.    
Stepping Stones is a participatory programme aiming to prevent HIV through 
improving gender equity in relationships, and thereby decreasing sexual risk 
behaviour. This programme was adapted for the South African context, and 
implemented and evaluated through a cluster randomised controlled trial. The trial 
was unable to show a decrease in HIV incidence, but did demonstrate a decrease in 
incidence of Herpes simplex virus 2, and men who underwent the intervention 
reported perpetrating IPV significantly less often after 2 years of follow-up [51].   
Other instances exist, for example the SHARE project and SASA! Study in Uganda 
[52,53] and a study comparing different combinations of interventions aiming to 
promote gender equitable behaviour in Brazil [54]. In addition, a recent systematic 
review of IPV prevention interventions specifically targeting adolescents, found that 
half of the included trials were effective [55]. A trial of a structured home visitation 
programme for high risk pregnant women in the Netherlands showed a decrease in 
IPV in the intervention group [56+. The long term effects on the participants’ 
children are as yet unknown.   
These examples not only demonstrate that IPV can be prevented through the efforts 
of the health sector acting in concert with other stakeholders, but also highlight the 
importance of addressing gender inequity when responding to IPV.   
Women’s perspectives on IPV care 
The WHO clinical and policy guidelines for responding to intimate partner violence 
and sexual violence against women advocate for woman-centred care [1]. Much 
literature on the topic of women’s experiences and expectations of health services 
in the context of IPV is available. This includes articles synthesising qualitative 
research in an attempt to increase evidence availability for policy-making and 
programme design [57,58]. There are many points of commonality, bearing in mind 
that the majority of this research was conducted in developed countries. 
Consistently, women who have experienced IPV have described an appropriate 
response by health care providers to be non-judgmental, understanding and 
empathetic [57,58]. Women want their health care providers to understand the 
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complexities and consequences of living with violence and the difficulties they face 
because of it [58,59]. They also want an acknowledgment from their providers that 
what they are experiencing is abuse, and that it is unacceptable and wrong [60,61].  
When these features are present the encounter can be validating and helpful, and 
raising the issue of violence can be viewed as caring [58,62]. When they are absent, 
however, and particularly when the health care provider neglects psychosocial 
aspects of care, the encounter can be detrimental [59], and can lead to a reluctance 
to disclose violence in the future [57].  
Another feature women have described as being of central importance is having 
health care providers respect their autonomy [60,62]. However, one survey found 
that 71% of women who disclosed IPV reported feeling their health care provider 
wanted them to leave their relationship, and 37.5% reported that they had been 
directly advised to do so [63]. Women have also expressed feeling judged when 
they did not follow the advice of providers to leave their relationship [58,61].  
Consistent with the need for a non-directive and validating encounter, South African 
women experiencing IPV reported that counselling was the service they most often 
wanted (between 36.1% and 45.8% in different provinces) [6].    
Common barriers to accessing help through health services include fear of the 
abuser and fear of having children removed from the home as a consequence of 
disclosing violence [57,58]. Related to the provider, the fear of judgment and not 
being believed or understood [58,59], as well as the fear of loss of confidentiality 
are common barriers [57,58,62]. At a systemic level, the lack of privacy often 
encountered in health care settings and a lack of continuity can prevent disclosure 
[57].   
 Overall, the appropriateness of the health care encounter depends on the 
empathetic and non-directive attitude of the provider, the attention paid to 
emotional issues and the maintenance of confidentiality. If these elements are 
present, having a health care provider raise the issue of violence is usually viewed 
by women experiencing IPV as supportive and helpful [58]. 
  14 
 
Health care provider perspectives  
Access to reproductive health services can be significantly affected by the attitudes 
of health care workers [64]. In the case of IPV, perceptions regarding the role of the 
health system and health care workers in intervening for IPV, and attitudes 
regarding the underlying causes of violence can influence how a patient is managed 
[65].  
Health care workers have dual roles, as care givers and community members, and 
often share cultural understandings of violence with their communities. They also 
experience a similar prevalence of violence to the rest of the community [66].  
In a rural South African setting, primary health care nurses were found to reflect the 
dominant culture of normalised violence, expressing a preference to deal with 
abuse within the family structure. Both male and female nurses perceived abuse as 
a form of discipline, often caused by the actions of abused women. A distinction 
was drawn between “normal” levels of abuse and abuse resulting in very severe 
injuries, for which it was considered more acceptable to seek outside help [66]. 
Addressing IPV remains a challenge for many health care workers, with studies 
citing numerous barriers to responding appropriately. On a provider level, these 
include discomfort dealing with emotional issues [67,68] and unrealistic 
expectations about the outcome of intervention [65]. One survey found that most 
(58%) health care workers had unrealistic expectations of IPV intervention [69]. This 
highlights the need to address how health care workers understand the 
complexities of violence, in particular the realities of why women remain in violent 
relationships. The same survey found that providers were able to empathise with 
women who were financially unable to leave their relationships, but were less 
empathetic towards middle-class or educated women who didn’t leave their 
partners [69].  
In medical culture, the view of the health care provider as the decision-maker in the 
patient-provider relationship is prominent [70]. This can affect how providers see 
their IPV encounters, in that a woman choosing not to follow advice, and either 
leave the relationship or seek legal redress, could be interpreted as a failure of the 
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interaction. The provider’s inability to provide a solution to the problem may be 
seen as an inability to intervene effectively [65].  
On a systems level, a lack of time has been cited in many different settings 
[67,68,71,72]. A Malaysian study found that although providers lacked time to 
appropriately deal with IPV, whether or not this impacted on the provision of care 
depended on individual providers varying interest in responding to violence [65].  
A lack of training is also a common barrier [72,73], with evidence suggesting that 
those health care workers who have had training tend to ask about IPV more often 
[74] and intervene more [75]. A survey of doctors in South Africa reported that only 
9.7% of respondents had received any IPV training [76]. Similarly, a lack of protocols 
is perceived by providers to inhibit IPV management [67,73] and those who have 
protocols available report assisting patients more often [75].   
Further systemic barriers include ineffective referral networks [68,72,73] and 
inadequacies of the health care setting in terms of creating a trusting and private 
environment [67,71].    
There appears to be some disparity between what women experiencing IPV want 
from health services and what the health system is currently providing. While 
women feel validated when an understanding of their complex situation is 
displayed, health care providers are undertrained in IPV, and may have unrealistic 
expectations. While women want non-directive counselling and support, health care 
providers may be uncomfortable with psychosocial issues and want to offer 
assistance in the form of advice, usually to leave the relationship or get legal help. In 
addition, system level barriers impact on the ability of providers to offer appropriate 
care, and social and structural barriers impede access.   
Further research needs 
There is sufficient evidence that IPV is a common and serious public health concern, 
and that addressing IPV in health services has the potential to improve outcomes. 
Further evaluations of health sector responses to IPV are needed, to assist health 
systems to determine the most appropriate models of care and how these can be 
  16 
 
integrated into current systems in the context of multiple systemic and societal 
barriers. Further research is needed to explore how best to support health systems 
in providing IPV care, including ensuring health care workers have the appropriate 
skills to intervene, how to operationalise intersectoral approaches to IPV in health 
systems, and how to improve access to, including acceptability of, services. 
Evaluations, including process evaluations, of scaled up programmes are also 
needed, to provide guidance on the roll out of evidence-based interventions.  
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Abstract  
Background 
Despite a high burden of disease, in many health districts in the Western Cape, 
South Africa, intimate partner violence is known to be poorly recognised and 
managed. To address this gap in service an innovative intersectoral model for the 
delivery of comprehensive intimate partner violence (IPV) care was piloted in the 
Witzenberg, a rural, agricultural sub-district known to have a high incidence of IPV. 
It was not known whether the initiative was a success from the perspective of the 
women using the service, from the service providers or from the managers.   
Methods  
A qualitative evaluation was conducted. Ten service users were interviewed to 
explore their experience of the intervention. Two focus groups were conducted 
amongst health care workers, and one focus group and six interviews were 
conducted with the intersectoral implementation team, to understand their 
experience of implementing the intervention. Documents relating to the pilot were 
also analysed. A contextualized thematic content analysis approach was used, 
triangulating the various sources of data, and utilising inductive as well as deductive 
approaches.     
Results 
Over the pilot period 75 women received the intervention. Study participants 
described their experience of it as overwhelmingly positive, with some experiencing 
improvements in their home lives. Significant access barriers included unaffordable 
indirect costs, fear of loss of confidentiality, and fear of children being removed 
from the home. For health care workers, barriers to inquiry about intimate partner 
violence included its normalisation in this community, poor understanding of the 
complexities of living with violence and frustration in managing a difficult emotional 
problem. Health system constraints impacted on the pilot, affecting continuity of 
care, privacy and integration of the intervention into routine functioning, and the 
process of intersectoral action was hindered by the formation of alliances. 
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Contextual factors, for example high levels of alcohol misuse and socioeconomic 
disempowerment highlighted the need for a multifaceted approach to addressing 
intimate partner violence.  
Conclusion  
The results of this qualitative evaluation draw attention to the need to take a health 
systems approach and focus on contextual factors when implementing complex 
interventions. They will be used to inform decisions about instituting appropriate 
intimate partner violence care in the rest of the province. Additionally, there is a 
pressing need for clear policies and guidelines framing intimate partner violence as 
a health issue.    
Keywords 
Interpersonal violence, Intimate partner violence, Domestic violence, Spouse abuse, 
Mental health, Health services, Health systems 
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Background 
Intimate partner violence (IPV) is a pervasive and complex issue that characterises 
partnerships worldwide. Almost 30% of women who have been in a relationship 
globally report having experienced physical or sexual IPV. In the World Health 
Organisation (WHO) Africa region this figure is 36.6% [1]. In South Africa, 
interpersonal violence is the second highest contributor to years of life lost, after 
HIV [2]. Of this very high burden, in women IPV accounts for 62.4% [2], and 42.3% 
of working men have reported perpetrating physical violence in a relationship [3]. 
These figures are likely to be underestimates, as the stigma surrounding IPV often 
leads to underreporting [4]. In addition, they focus on physical and sexual abuse, 
and exclude emotional abuse which is less well described but appears to have a high 
prevalence and serious mental health implications [5].  
For women experiencing intimate partner violence, negative effects span all aspects 
of health, from direct mortality to increasing risk factors for poor health outcomes. 
Mortality can be caused through homicide, or indirectly through suicide [6], 
maternal causes [7] and as a consequence of HIV infection [8]. Morbidity could be 
due to multiple causes, including physical trauma, psychological trauma and stress. 
In addition, the controlling behaviours of perpetrators can lead to limited 
reproductive control and lack of autonomy in health seeking behaviour [1].  
Recognition that IPV is an important public health concern is increasing, and has 
recently been supported by the publication of the first WHO clinical and policy 
guidelines for responding to IPV and sexual violence [9]. Despite this, there is 
limited literature describing scaled up programmes or integrated health system 
responses [10]. 
Following the publication of a trial of universal screening for IPV that showed no 
improvement in quality of life or mental health outcomes [11], it appears that 
utilising a case-finding approach during health care encounters and responding in a 
woman-centred way, is likely to be of more value [12]. The challenge for health 
systems is to integrate IPV identification and management into health services in a 
way that has reasonable sensitivity and addresses systemic constraints to providing 
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this kind of care.  
Many barriers to successful implementation of IPV programmes have been 
reported, on both provider and systems levels. Health care workers’ (HCWs) 
attitudes toward IPV and other reproductive services affect both women’s 
utilisation of services and the quality of the interaction [13,14]. In another rural 
area of South Africa, nurses working in primary care experienced a similar 
prevalence of violence, and expressed similar values and attitudes about IPV, as the 
rest of their communities [15]. Discomfort dealing with emotional issues [16] and 
the unrealistic assumption that women should always leave, and always want to 
leave violent relationships, may also affect providers’ confidence in intervening for 
IPV.   
On a systems level, HCW concerns include lack of time during consultations 
[16,17,18], lack of training for HCWs, both prequalification and in-service [17,19], 
weak referral networks [16,17,19], lack of confidence in management support [20], 
insufficient flexibility and policy constraints [10]. On a policy level, political 
commitment translated into clear policies and protocols, is necessary for successful 
IPV intervention [20,21]. 
In the South African primary health care system, despite the significant burden of 
disease, there is no standardised protocol in place for identifying or caring for IPV, 
resulting in generally poor recognition and inconsistent management [22]. In an 
attempt to address this, a pilot project implementing a model for comprehensive 
IPV care in a rural sub-district of the Western Cape Province was undertaken 
between April 2012 and March 2013. The project was an intersectoral collaboration 
between the provincial Departments of Health and Social Development and the 
University of Stellenbosch, and aimed to integrate the intervention into the health 
system of the sub-district, with the intention of future expansion.  This study is a 
qualitative evaluation of the pilot’s implementation.  
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Methods 
Setting 
The Witzenberg is a rural sub-district of the Cape Winelands District in the Western 
Cape, South Africa. It had a population of 115 946 in 2011 [23]. The Cape Winelands 
is considered to be a tourist attraction, but experiences wide socioeconomic 
disparities. In 2010, the Witzenberg had the highest age-standardised all-cause 
mortality rate in the Western Cape [24]. It is largely agricultural, and much of the 
work is seasonal, with migrant workers coming into the area during harvest season. 
Rural farm-worker communities in the Western Cape are generally characterised by 
a poor standard of living and access to services, as well as pervasive alcohol abuse. 
Women work in this context under particularly adverse conditions, and gendered 
power inequalities are further entrenched by unequal labour practices [25].  
In 2012, there were nine fixed primary care facilities and one district hospital in the 
sub-district, as well as mobile health and community-based services. The sub-
district was poorly resourced in terms of mental health services, with one mental 
health nurse and one full-time equivalent psychologist.  
The model 
A description of the development of the piloted model has been published 
elsewhere [26]. The first step is the identification of women experiencing IPV, using 
a targeted case-finding approach. The focus is on recognising cues in women 
presenting to primary care, for example vague, nonspecific symptoms, headaches 
and mental health complaints, as well as conditions that are known to be associated 
with IPV, such as HIV and other sexually transmitted infections. Women are asked 
about violence, managed clinically and offered referral to a dedicated IPV service. 
This dedicated service was provided by a social worker employed by the 
Department of Social Development in the primary care facility closest to the user’s 
home, with an intern providing back up in case of illness or annual leave. A social 
worker was chosen to deliver the service in recognition of a joint mandate for IPV, 
and because of the limited amount of time nurses have available in each primary 
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care encounter. The social worker had half her time, or ten working days a month, 
allocated to the pilot, which translated to one day a month being spent at each 
facility. The design of the pilot was to utilise staff already engaged in service 
provision, so as to assess whether the service could be implemented in other 
settings with similar human resource availability and burden of disease.  
The service is comprehensive, encompassing psychosocial and legal care. The first 
contact with the user is an assessment and intervention, and is conducted according 
to a protocol, covering a full history of abuse and previous attempts to access help, 
a safety assessment and development of a safety plan, case-finding for mental 
disorders (including screening for alcohol abuse), counselling, and referral to 
appropriate resources (see figure 1).  
Following this contact, according to the model, users should enter a life-skills group 
facilitated by the same provider and covering issues relating to self-efficacy, self-
care and motivation to change. There are five sessions, whereafter community 
based support groups should provide ongoing peer support, facilitated and co-
ordinated by the Department of Social Development. However, during the pilot 
period neither of the group phases of the model was implemented as it was felt not 
to be practical during the start-up phases. There was no replacement protocol for 
follow up, and the service provider determined whether and how users were 
followed up according to her usual methods of working.   
The implementation team held monthly meetings to address operational issues and 
the psychologist working in the sub-district was available to provide support to the 
service provider should she experience vicarious traumatisation.  
Training was provided by the University of Stellenbosch. Several two hour sessions 
were facilitated for HCWs, resulting in 52 nurses and nine doctors receiving training 
(48% of HCWs in the sub-district, achieving coverage of all facilities). The content 
was identification of women experiencing IPV, attitudes and misconceptions 
surrounding IPV, and the model and how to work with it. The social worker 
providing the service, as well as 19 other social workers working within the sub-
district, received more extensive training over four days. This included motivational 
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interviewing, mental health assessment, use of the protocol, life-skills and support 
groups.  
Resources provided to the pilot consisted of the Department of Health funding 
training and technical support from the University of Stellenbosch, and the 
Department of Social Development allocating the service provider and her routine 
operational costs, for example transport. There was no specific operational budget 
for the pilot, and no dedicated staffing.    
Study Design 
A qualitative evaluation of the pilot was conducted, aiming to understand how the 
model was implemented. The experience of the process by implementers, 
providers, intervention- users as well as the extent of, and potential for, integration 
of the model into health system functions were explored. A qualitative, process 
evaluation was considered to be most appropriate, firstly because of the pilot 
nature of the intervention, meaning the details of how implementation occurred 
were of particular interest, and also because of the context-specific and sensitive 
nature of IPV.  
To examine users’ perspectives, semi-structured interviews were conducted with 
ten women. They were selected purposively, with HCWs identifying women who 
were likely to be forthcoming about their experiences, and attempting to cover a 
range of facilities, including those in more remote areas.  
Two focus groups were conducted with HCWs, one with primary care level nurses, 
and one with doctors and nurses from the district hospital, in order to explore their 
experiences of implementing the intervention. All interested HCWs were invited to 
attend the focus groups, resulting in groups of six and nine. Only the district hospital 
operates 24 hours a day and the emergency centre is responsible for seeing all 
trauma cases. Primary care facilities and the district hospital were differentiated 
because women present to them differently and follow different pathways of care.  
All members of the implementation team were interviewed. One focus group was 
conducted, consisting of managers from the Department of Health, with the 
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exception of the project leader, with whom a semi-structured interview was 
conducted. This encouraged the sharing of both positive and negative viewpoints of 
the project team. In addition, semi-structured interviews were conducted with the 
social worker providing the intervention and her supervisor from the Department of 
Social Development, as well as the members of the implementation team from the 
South African Police Service and the University of Stellenbosch.     
Documents relating to the pilot were analysed, including initial proposals and 
agreements and minutes of the implementation team meetings. Monitoring data 
assessing the number of appointments and the number of women who received the 
service, as well as their characteristics, were used along with the documents, 
interviews and focus groups to build a picture of the implementation process. Table 
1 outlines the sources of data and collection approaches.  
Data was collected in March and April 2013. The principal investigator conducted 
the interviews and facilitated the focus groups, in English or Afrikaans depending on 
the preference of participants. All audio recordings were translated into English and 
simultaneously transcribed.  
Discussion schedules were used for each category of participant and data collection 
method. For service users, discussion schedules covered their experiences of the 
service, including their experiences of being asked about violence during a health 
care encounter, previous attempts to access help, expectations of the service, and 
benefits and harms as a result of the service. Managers and service providers were 
asked about their experiences of working on the pilot, including challenges and 
successes; how it affected daily functioning, training, and support; and experiences 
with intersectoral work. In addition, questions were asked about the perceived need 
for the intervention, and what role each department and professional should play in 
intervening for IPV. 
Analysis 
In order to analyse the integration of the model into health systems functions, a 
conceptual framework developed by Atun et al. was used [27]. Integration is 
defined as: “the extent, pattern, and rate of adoption and eventual assimilation of 
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health interventions into each of the critical functions of a health system” *27+, and 
five key components are identified that interact to affect the adoption of 
interventions. These are the type of problem targeted by the intervention, the 
intervention itself, the adoption system (made up of multiple interconnected actors 
and the context within they operate), health system characteristics and the broader 
environmental context. The health system is viewed as a complex adaptive system. 
This pilot can be viewed as a complex intervention (less easily reproduced and 
needing more adaptation to integrate into local context), largely because success 
depends on high user and stakeholder engagement and behavioural factors.  
To achieve an in-depth understanding of how the intervention was implemented, 
thematic analysis was used (as described by Braun and Clarke) [28]. This approach 
was chosen for its flexibility and ability to explore patterns and underlying 
relationships, while preserving the influence of context [28]. It involved multiple 
readings of the transcripts, documents, and field notes, and an exploration for 
themes, grouping them and looking for connections, an inductive approach. This 
was followed by an exploration of the data using the Atun et al. conceptual 
framework described above [27], a deductive approach. Different categories of 
participants and data types were analysed sequentially. All data were iteratively 
coded and a code diary was kept. Data were organised using Open Code software 
[29]. Triangulation of data from all sources and respondents allowed a unified 
understanding to be developed, incorporating the viewpoints of all role-players. 
Contradictory data were purposely sought and examined to improve the 
trustworthiness of conclusions. Reflexivity was encouraged using field notes and a 
research diary kept throughout the evaluation. Final themes were based on the 
conceptual framework and modified in order to adequately describe the user 
perspective and integrate inductively generated themes. 
Ethical considerations 
Ethical approval was obtained from the University of Cape Town Faculty of Health 
Sciences Human Research Ethics Committee (reference 655/2012) and permission 
to conduct the research was granted by the Department of Health. Written 
informed consent was obtained from all participants, in English or Afrikaans 
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according to their preference.  
Results  
In this section, the number and characteristics of service users are described, 
followed by findings relating to their environment and experiences, and finally a 
description of implementation issues and barriers to care.   
In the 11 months during which the intervention was provided, 165 women had 
appointments for the service, and 75 women received the initial intervention 
according to the protocol. Only 45% of those who were referred and successfully 
made an appointment attended. No community-based support groups took place, 
and only the first of five life-skills group sessions was facilitated at two venues. 
These numbers were felt by the implementation team to be low, and raised 
questions about whether this was a justifiable use of the service provider’s time. 
The characteristics of users are presented in table 2 (missing responses are not 
included within categories). 
The median age of users was 32 years, ranging from 16-58 years, and severe abuse 
was experienced, with women reporting on average nine different forms of abuse. 
Eighty-two per cent of women were scored as being at high or severe risk of injury 
or death, according to the safety assessment contained in the protocol for care, 
modified for the South African context [30]. Forty-eight per cent had not previously 
accessed legal assistance, and 65% were referred for further mental health 
assessment.  
Ten women were interviewed in an attempt to understand how users experienced 
the intervention. They were spread over six different primary care facilities. 
Compared to the rest of the service users, they had similar demographic 
characteristics and the abuse they experienced was of a similar severity. However, 
more of the interview participants had previously accessed legal help and were 
referred for further mental health assessment. The participants are described in 
table 3.  
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Environment 
Both users and HCWs described living in an environment permeated by violence. 
Users experienced physical, emotional, financial and sexual abuse at the hands of 
their partners, as well as their partners’ families or their own family members. They 
described living in fear and anger, in some cases leading to the perpetration of acts 
of violence against their partners. High levels of alcohol misuse were perceived to 
be associated with IPV and family and community violence.  
“Because as soon as I am sober, then [he] upsets me. He comes to me with his drunk 
things, and says things and how do I take it? ... He doesn’t hit me when he’s sober. 
He doesn’t mess with me. But if I’m drunk and he’s drunk...” (Interview 15) 
“So we live in a very violent sub-district, and it’s nearly all alcohol-related.” (Focus 
group 1)  
IPV was understood to be a social norm, with traditional gender roles holding sway. 
Women had very little autonomy, particularly over sex in their relationships. They 
were deeply disempowered socially and economically, and were expected to fulfil 
the roles imposed by a patriarchal society.  
“Because he still hurts me every day. And when he’s at home I must play the darling 
wife, I must do what he wants and I must sleep with him… I am really trying my best 
to be a wife to him and respect him in everything he does… And then people come 
from outside and they say, wash his clothes, show him how you feel. You are still his 
wife, wash and iron his clothes. Get his food ready.” (Interview 5)   
Users’ experience of the intervention 
Participants appreciated having someone listen to them and share the weight of 
their problems, and experienced cathartic feelings of release as a result. For many, it 
was clear that they had not had this experience outside of the service, due to 
limited social support.     
“But I know she can listen to all my problems that I have. I don’t have to bottle it up. 
I don’t have to sit every time and think, oh, what must I do now so he can stop 
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shouting at me like that?” (Interview 3) 
“It was a very good experience that day. I also felt sad when I had to talk about it, 
but after I spoke about it I felt a lot better. I felt relieved once a spoke about it.” 
(Interview 4) 
“She listened to all my stuff, and the way I summed her up, she shared my feelings.” 
(Interview 6) 
“When I was done talking to her, everything was alright again. She understood me 
and I understood her… It went very well. We spoke like people who knew each 
other… when I was in conversation with her, everything disappeared from me.” 
(Interview 8) 
The understanding, support and validation they felt they received was of increased 
importance in the context of isolation imposed by the controlling behaviour of 
abusers, the feelings of shame associated with abuse, and the constant negative 
input of emotional abuse.  
“What was in my heart, I poured it all out… and I felt like a person again.” (Interview 
4) 
“I felt good… because I was able to talk to someone who was maybe able to 
understand me; someone who said something to me that was positive.” (Interview 
5)  
“I felt she cared… then I could feel there is someone who cares for me…That day I 
was done with her I felt like a brand new person. I had courage, a lot of courage to 
go on.” (Interview 8) 
“I felt that which she gave me healed me a bit afterwards.” (Interview 9) 
The intervention and the positive experience of being heard and supported led to 
improvements in communication within relationships, or with children, although 
temporary in some cases.    
“But with me and my children a lot of things changed. Because I talked to them…” 
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(Interview 5) 
“It went well for a few days. I spoke to him, and told him what he must give to me 
and what I need from him. But… it’s just fighting every time.” (Interview 6) 
“It was a little better. There is still arguing now and then, but it is not so bad 
anymore. Because we understand each other at home now. There is not such a lot of 
alcohol at home anymore.” (Interview 9) 
“In my house I changed a lot of things, because I feel me and my children are much 
closer to each other than we were. And we can talk to each other especially me and 
my eldest daughter, we can talk openly…” (Interview 13) 
No harms were reported as a consequence of the intervention and there was 
variation in whether partners were informed of the reason for the visit. However, 
confidentiality was an overriding concern, particularly relating to the clinic 
environment.     
“That time a lot of one’s personal things leaked here. That is why I am very cautious 
when I come to the clinic. I will not easily walk in here and go and talk to a sister 
because I know what has happened before.” (Interview 14) 
A dominant theme was a desire for services to work with men. Participants 
recognised that those perpetrating the abuse have a lot of “stress” and difficulty 
communicating, particularly regarding their own emotions. Alcohol and substance 
abuse were also identified as major underlying factors needing to be addressed. In 
addition, offering help to women experiencing abuse and not the perpetrators was 
interpreted by women as neglecting to address the cause of the problem.  
Access   
Access can be conceptualised as the degree of fit between health systems and users 
across three dimensions: availability, affordability and acceptability [31]. Access 
barriers were identified in each of these domains, either relating to access to health 
services in general, or to this intervention in particular.  
Availability of the intervention was very limited in that it was provided only once a 
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month at each fixed primary care facility. This was due to a lack of resources, with 
one service provider having ten days a month dedicated to the intervention, spread 
over a large geographical area. The timing of the intervention was problematic for 
the same reason, with women having to wait up to a month from the time of their 
referral. This is likely to have affected their motivation and readiness to attend.  
Although primary health care is free in South Africa, indirect costs including 
transport and loss of income, made the intervention unaffordable to many women. 
Seasonal employment is common in the area, and workers are not paid for time off 
to attend clinic appointments.     
“Because you don’t get paid if you don’t come to work. You can be sick and come to 
the clinic, but you don’t get paid… I feel at least I’m working, and it helps me to earn 
a few cents for the two boys and the girl.” (Interview 4)  
Threats to acceptability included fears that children would be removed from their 
mother’s care as a result of any interaction with a social worker. Women feared 
social workers would be likely to take children away from the home if violence or 
drinking was disclosed. This led to reluctance to attend appointments.  
“A lot of times people told me your child will be taken away and all those things... 
The only thing I had in the back of my mind, I just waited for the moment they will 
take away my child. And then I told her everything, and then she explained to me 
what she came to do. She also said she isn’t coming to take away the children.” 
(Interview 8) 
“All I could think about was that I have children in the house and these things are 
happening in the house, and that they might take the children away.” (Interview 13) 
Confidentiality was an important concern in light of the small communities to which 
people belong and the stigma associated with IPV. Participants feared their partners 
would find out about the visit either through a breach of confidentiality or a 
community member seeing them at the clinic. An associated fear was that a visiting 
a social worker would identify them as having social or mental health problems.  
Finally, there was a misconception amongst both users and HCWs that the 
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intervention was largely about legal redress for IPV. This has previously been the 
dominant response of the health services, and women were wary that they may be 
pressurised to lay a charge against their partners if they attended.  
Implementation 
The support and resources required to implement an intersectoral intervention 
having this level of complexity were underestimated at strategic level. The 
motivation to work intersectorally stemmed from the recognition of a joint 
mandate, but also from a desire to share resources and capacity in an under-
resourced environment. The intersectoral nature of the implementation team led to 
additional complexities both in terms of the structure of the intervention and 
relational issues between partners at various levels. The scale of the intervention 
(service provision through multiple service delivery platforms in a large geographical 
area) further added to these challenges.    
In the planning phases, the intersectoral team failed to adequately clarify roles. 
During the process of adapting the model for implementation, the local 
implementation team felt that they had not been adequately consulted and had 
been allowed insufficient flexibility. A change in managers responsible for the pilot 
at this crucial stage contributed to divisions during the adaptation process, and may 
have negatively impacted ownership. Further, engagement between the 
implementation team and service providers (both HCWs and social workers) was 
absent. This led to a lack of trust and resistance from service providers in the initial 
phases. When attempting to provide supervision to service providers, complications 
regarding rigid management hierarchies and communication challenges led to the 
formation of alliances, further decreasing trust. At a service delivery level, this may 
have negatively impacted the quality of the intervention, as  service providers were 
not as receptive to the ongoing training and mentoring that was offered as they 
could otherwise have been.  
At a strategic level, not all partners were adequately represented on the 
implementation team in terms of decision making power, and levels of support for 
the intervention from higher management structures varied.  
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Health System barriers    
Participants in this study identified that IPV is likely to require more than one user-
provider interaction, and that continuity of care would be crucial in providing 
appropriate care over a sustained time period. The South African primary health 
care system has historically been geared toward acute episodic care [32], and 
continuity of care remains a challenge. The primary health care system is also 
geared to curative care, and HCWs usually do not have the counselling skills needed 
to facilitate behaviour change. 
Other system level barriers to implementation existed. Inefficient referral systems 
often put the onus on the user to make appointments which may have required 
taking time off work or making expensive cellular phone calls. There was also a lack 
of time in the consultation to introduce subjects that may lead to difficult and 
lengthy discussions, and multiple things to remember in the context of 
comprehensive care led to HCWs forgetting to inquire about IPV. Mental illness and 
social problems are also stigmatised, and privacy is difficult to maintain due to 
infrastructure and systems constraints. Confidentiality is a concern for users, and 
participants expressed fears that confidentiality would be lost, either through HCWs 
or community members who may have witnessed them attending this service.   
The role of the health system in addressing IPV was dominantly understood to 
consist of identifying women experiencing IPV and linking them to further services, 
but not taking primary responsibility for their care. This was consistent with how 
this pilot was implemented, as social workers were responsible for comprehensive 
(excluding medical) care. However, the ingrained perception that IPV is not a health 
problem is likely to have impacted negatively on the integration of inquiry about 
violence into routine HCW functioning.   
“Because the actual bigger body of the whole thing lies with the counselling, and 
that's the social worker's role. The bigger role is definitely with the social worker and 
not with health. Health, definitely to identify and to refer… but the core function lies 
with the social worker.” (Focus group 1) 
The perception from the user perspective that the health services would not be an 
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appropriate place to discuss emotional or social problems, or that HCWs would 
respond only by directing users to legal interventions, appears to have been a 
significant access barrier.   
Provider level barriers 
Lack of experience on the part of the social workers as well as a perceived lack of 
commitment, due at least in part to resource constraints (for example difficulties 
accessing transport and telecommunications), led to decreased levels of confidence 
in the intervention from HCWs. Booking women for the service who subsequently 
did not come, general feelings of hopelessness when confronted with the possibility 
of intervening in IPV, and frustration generated when women not leaving violent 
relationships was interpreted as a failure of the intervention, compounded this lack 
of confidence and impacted negatively on referrals.    
The professional values of service providers have previously been found to be 
important in providing IPV care [26]. Similarly, in this pilot, it was found that 
complete implementation would have required exceptional commitment, 
particularly as the social workers had to advocate for a new service while working in 
the health system for the first time. Other factors that affected the capacity of the 
social workers included a high concurrent case load, lack of management support 
and organisational limitations. Limited mental health knowledge and skills, and 
viewing mental health as outside of their scope of practice, led to reluctance to 
tackle the mental health aspects of the intervention, and additional training and 
mentoring were required to ensure this was done adequately.  
Support from a psychologist, attempting to mediate the effects of vicarious 
traumatisation for service providers, was offered but not taken up, suggesting that 
this type of support needs to be provided in a more structured manner.  
Social barriers 
High levels of violence experienced in this community and widely accepted 
traditional gender norms have led to some HCWs accepting that IPV is a normal part 
of life. There was an underlying lack of understanding of the complexities of living 
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with violence and trying to leave a violent relationship. The gendered aspects of IPV 
were often overlooked. IPV as a health condition was defined according to the 
severity of abuse, and whether HCWs felt that users’ situations warranted referral. 
Users missing appointments was also interpreted as an indication that they did not 
need or desire the service.  
“Then I would ask them, but why did you not refer? And they would say to me, but 
you know, that has been happening for so long... And some of them will even say to 
me, but you know, they wanted it or they asked for it. Something happened and she 
actually made her husband angry, so it isn’t really intimate partner violence… so it’s 
actually okay, so why refer?” (Focus group 1) 
“So you must have the time to get behind what's really going on: is it really domestic 
abuse or what, or is it something that happened only once.” (Focus group 2)   
In the district hospital, HCWs were so used to violence that women presenting with 
assault by a partner were regarded as a normal occurrence and not singled out for 
further psychosocial management.  
Discussion  
This pilot represented an attempt to integrate a complex intervention for 
comprehensive intimate partner violence care into a rural district health system, 
which is not well suited to the care of chronic conditions, lacking mental health 
resources and with numerous barriers to access. IPV is a phenomenon with complex 
social and structural roots. Poverty, gender inequality and alcohol misuse are 
entrenched in the Witzenberg, and women are more vulnerable to exploitation in 
this agricultural community than their (already socioeconomically disempowered) 
male counterparts. For an intervention to have a significant impact, the stigma 
surrounding IPV as well as underlying values and attitudes to gender would have to 
be transformed, amongst both service providers and community members.  
User experiences of the intervention were overwhelmingly positive, in some cases 
leading to improvements in their home lives. WHO guidelines recommend that a 
woman-centred approach be taken when responding to IPV [9]. Literature on 
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women’s expectations and experiences of health services shows that they want 
health care providers to be non-judgemental, empathic and understanding and to 
provide validation [33,34,35], and that when these features are absent, the 
encounter can be damaging rather than helpful [36]. In a South African study the 
service women reported wanting most often was counselling [4]. Users described 
experiencing the approach of the intervention as consistent with these guidelines. 
They felt understood, supported and validated and appreciated being listened to. In 
the context of poor social support and imposed isolation, these features were 
valued. 
The guidelines further recommend assisting women to access information and 
resources, assisting them to increase safety and providing or mobilising social 
support [9]. Referrals to mental health services in this pilot were high (although 
referral pathways were not always effective) but facilitating access to other 
resources was less successful. Referral networks both within the health system and 
between other agencies need to be strengthened to support continuity and allow 
women access to further community resources. A lack of structured follow-up also 
contributed to gaps in continuity of care. The high number of mental health 
referrals is consistent with a previous South African study that found 66.4% of 
women obtaining protection orders against their partners to have severe depression 
symptoms, and 51.9% to have severe PTSD symptoms [37]. It also highlights the 
importance of mental health skills and experience in IPV care providers. 
Both users and implementers expressed a desire for services to work with men, 
both because they were perceived to need psychosocial support, and in addressing 
violence in the home. How to intervene with men should be considered, in the 
context of health services that are often not appropriately geared to meet men’s 
needs, as well as prevailing constructions of masculinity negatively influencing their 
utilisation of health services [38].  
During the time period of the pilot, the police services of the largest town in the 
Witzenberg recorded 373 domestic violence complaints (A. Douglas, personal 
communication, July 2013). This underlines the significant number of women 
actively seeking help for IPV, albeit not from the health services, and led to the 
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implementation team viewing the number of users generated by the pilot as 
inadequate. Expectations that because levels of violence are high in the area, 
women would be readily identified proved unrealistic, because of the complex 
social and structural factors underlying IPV, as well as health system constraints. 
Reasons for low referrals to the intervention and low attendance amongst those 
who were referred included access constraints that affect health services more 
generally and specifically relating to the service, as well as provider, system and 
societal level barriers to HCWs inquiring about IPV.   
Availability of the intervention was limited, and the costs of missing work or finding 
transport often made it unaffordable. Key threats to acceptability included a lack of 
trust in the confidentiality of the health services, often cited in the literature as a 
barrier to disclosing IPV [33,35,39], as well as a fear that disclosure would lead to 
social workers removing their children from the home.  
Important barriers to HCWs inquiring about violence included the normalisation of 
IPV leading to HCWs giving the intervention a low priority. Access to reproductive 
services is significantly affected by HCWs attitudes [14], and whether and how they 
inquire about IPV is crucial to successful intervention, despite the dedicated IPV 
service being provided in a manner acceptable to users.  
Poor recognition that IPV is a valid health problem, and the perception that the 
health system plays a limited role in providing IPV care, also affected attitudes 
toward the intervention. Coherent national and provincial policy frameworks are 
needed to begin to shift these views, furthering the efforts of the WHO in 
publishing clinical and policy guidelines which clearly frame IPV as a health issue.  
The piloted model allows for integration of services from the perspective of the 
HCW, with the primary care provider inquiring about IPV and providing initial 
medical care and referral. This was not fully achieved, however, and neither the 
dedicated IPV service, nor other health system functions such as training and 
governance, were integrated. There is no consensus that interventions targeting 
specific health problems should always be fully integrated [40], but the current 
reengineering of the primary health care system towards comprehensive primary 
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care suggests that integration would lead to better sustainability. In addition, 
participants in management roles expressed that integration of services is a priority 
for them, and WHO guidelines recommend that IPV services be as integrated as 
possible [9].  
The challenging nature of working intersectorally was highlighted during this pilot, 
particularly relating to differing levels of management support, decentralisation of 
control and availability of resources, as well as lack of clarity regarding partners’ 
functions. The formal structures of intersectoral action were found to be important, 
but more significant were the effects of informal relationships, communication and 
shared ownership and understanding, and the formation of alliances proved 
destructive.  
A contradiction became apparent between the recognised need to deliver 
integrated services through intersectoral platforms, and the tight parameters within 
which managers and service providers are required to operate. The theory of 
professional closure, describing the carving out of exclusive professional definitions 
to create increased status or reward, can be applied to interactions between the 
various professionals involved in this intervention and their power dynamics [41]. 
Considering the development of professions in this light adds to an understanding 
of the difficulties inherent in working intersectorally.      
Implications 
The barriers to implementation described above require that a health systems 
approach be taken in considering scale up of this model, interrogating how all 
elements of the health system would be affected by implementation. In so doing it 
could attempt to strengthen referral systems, continuity of care, HCW skills and 
platforms for intersectoral action. A high degree of flexibility would be required, 
allowing adaptation to local context and resources. The service should be integrated 
into health system functions as far as possible in order avoid an unsustainable 
vertical service. In addition, the pervasiveness of alcohol and its links to violence 
highlight the need for a multifaceted approach to providing care for IPV.    
Longer term evaluation of this intervention is needed to examine user outcomes 
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and determine its effectiveness. Elements of the model, including the most 
appropriate professional to deliver the intervention, having the intervention 
situated in primary care facilities and engagement with the community, should be 
further refined before considering scale-up. There is a need for appropriate services 
for women presenting to the primary health care system who are experiencing IPV, 
as well as policies and protocols guiding these services, but the resource and 
management requirements for implementation should not be underestimated.   
Limitations 
This evaluation did not examine outcomes, so the effects of the intervention on 
violence, quality of life and mental health measures are unknown. Processes and 
context were explored, which will necessarily vary in different settings, limiting 
generalisability. However, health system barriers to providing IPV care are likely to 
be similar in similar settings. In addition, women who either declined the 
intervention or did not attend their appointments were not interviewed, so their 
perspectives were missed. It is very possible that other access barriers would have 
been identified had this not been the case.  
The principal investigator in this study was employed by the Department of Health. 
This may have impaired participants’ ability to answer certain questions critically. In 
terms of the users, social desirability bias may have been introduced. However, it 
may also be viewed as a strength as it allowed a fuller understanding of the 
organisational context within which the pilot was implemented.  
Conclusion  
This study evaluated the process of implementing a model for comprehensive IPV 
care in a rural sub-district of the South African district health system. It was an 
ambitious undertaking, requiring system-wide implementation, multiple 
stakeholders and external training, while fundamentally challenging entrenched 
value systems of privilege and power. Contextual factors such as high levels of 
alcohol abuse and the double exploitation of women in this farming community 
added to these challenges and point to the need for multilevel approaches to 
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addressing IPV.  
The pilot model was not fully implemented in that the group phases did not occur, 
and was hindered by barriers to inquiry about IPV (evidenced by low referral 
numbers) as well as by access barriers, including those limiting acceptability 
(evidenced by a low proportion of women keeping appointments). The value of a 
qualitative process evaluation has been demonstrated, and the findings will be used 
to inform decisions about instituting appropriate IPV care in the rest of the 
province.   
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Figures  
Figure 1- Model for IPV care implemented in the Witzenberg 
Flow chart describing the model of care implemented in the Witzenberg, including 
service providers responsible for each step during the pilot.  
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Tables  
Table 1: Data collection approaches and data sources  
Data collection approach Sources of data  
 Category Details  
Individual interviews 
(total=15) 
Service users 10 women 
Service providers  1 social worker 
Managers 1 Department of Health 
1 Department of Social 
Development 
1 SAPS 
1 University of Stellen-
bosch 
Focus groups 
(total=3) 
Service providers 1 primary care facilities   
 1 district hospital 
Managers 1 Department of Health 
Monitoring data Service users  Service records  
Document analysis  Minutes of meetings; Memorandum of Understand-
ing; proposals   
Field notes Principal researcher, kept throughout pilot  
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Table 2: Characteristics of service users 
Characteristics of service users during pilot (N=75) 
Age (median, IQR) 32 (25, 41)  
  Percentage (frequency)* 
Relationship to abuser Married 34% (22) 
 Cohabiting 41% (26) 
 In a relationship 11% (7) 
 Previous relationship 14% (9) 
Types of abuse Physical abuse 89% (58) 
 Emotional abuse 88% (57) 
 Sexual abuse 62% (40) 
 Financial abuse 51% (33) 
Frequency of abuse (2 
years) 
More than 20 times 40% (20) 
 10 to 20 times 24% (12) 
 Less than 10 times 36% (18) 
Safety score** High risk 54% (35) 
 Severe risk 28% (18) 
Previous legal help Protection order 34% (22) 
 Charge laid 48% (31) 
 Did not access help 48% (31) 
Referrals to mental 
health 
Any mental health 
referral 
65% (42) 
 Suspected depression 83% (35) 
 Suspected anxiety 19% (6) 
 Suspected PTSD  14% (8) 
 Suspected alcohol abuse 19% (8) 
 Suspected substance 
abuse 
5% (2) 
 Multiple suspected 
diagnoses 
33% (13) 
*Missing data not included  
** According to safety assessment in protocol for care 
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Table 3: Profile of interview participants 
 
Interview participants (n=10) 
 Median IQR 
Age 35 30, 43 
Months since intervention 6 5, 7 
  Frequency 
Interview site Clinic 6 
 Home 4 
Clinic at which intervention was 
received 
  
 Nduli 2 
 Tulbagh 2 
 Breerivier 2 
 Op Die Berg 2 
 Prince Alfred Hamlet 1 
 Bella Vista 1 
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Appendix A: Discussion schedule, managers focus group     
  
As you know, I am doing this research to try and understand what worked and what didn’t 
work in the IPV pilot project, and how we can improve the process in the future or in other 
places. I am interested in your experiences and your thoughts and feelings about the 
project. 
To start with, I’d like to understand what people’s roles were in the project. 
How did you find working on this project? 
What challenges did you encounter with this project? 
Prompts: 
 Rural area 
 Challenges working with IPV 
 Response from service providers 
 Response from patients 
Did you find that the intervention fitted well into the way the district health services 
normally run? 
Prompts: 
 Able to adapt the intervention to fit the system? 
 Referrals 
 Normal tasks 
 Time 
Do you think there is a need for an intervention of this kind? 
Prompts: 
 Burden of disease 
 Need in health services 
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 Need in this area 
How useful was the project? 
Prompts: 
 Does it meet the need? 
 Helpful for patients 
How could the project have been improved? 
How did the team implementing the project function? 
Prompts: 
 Communication 
 Conflict resolution 
 Morale 
How did you find working with other sectors? 
Prompts: 
 Advantages/disadvantages 
 What helped 
 What hindered 
Were the providers adequately trained and supported? 
What role do you think a nurse or doctor should play in IPV? 
Prompts: 
 Treating injuries 
 Detection 
 Mental health care 
 Forensics 
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 Counselling/advice 
 Referral 
What kind of role do you think the health services should play in IPV? 
Prompts: 
 Managing patients 
 Prevention 
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Appendix B: Discussion schedule, managers interview    
   
As you know, I am doing this research to try and understand what worked and what didn’t 
work in the IPV pilot project, and how we can improve the process in the future or in other 
places. I am interested in your experiences and your thoughts and feelings about the 
project. 
To start with, what was your role in the project? 
How did you find working on this project? 
What challenges did you encounter with this project? 
Prompts: 
 Rural area 
 Challenges working with IPV 
 Response from service providers 
 Response from patients 
Did you find that the intervention fitted well into the way the district services normally run? 
Prompts: 
 Able to adapt the intervention to fit the system? 
 Referrals 
 Normal tasks 
 Time 
Do you think there is a need for an intervention of this kind? 
Prompts: 
 Burden of disease 
 Need in health services 
 Need in this area 
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How useful was the project? 
Prompts: 
 Purpose of the project 
 Does it meet the need? 
How could the project have been improved? 
How did the team implementing the project function? 
Prompts: 
 Communication 
 Conflict resolution 
How did you find working with other sectors? 
Prompts: 
 Advantages/disadvantages 
 What helped 
 What hindered 
Were the providers adequately trained and supported? 
What role do you think a nurse or doctor should play in IPV? (For DSD: social worker; SAPS: 
police) 
Prompts: 
 Treating injuries 
 Detection 
 Mental health care 
 Forensics 
 Counselling/advice 
 Referral 
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What kind of role do you think the health services should play in IPV? (For DSD: social 
development; SAPS: SAPS) 
Prompts: 
 Screening 
 Managing patients 
 Prevention 
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Appendix C: Discussion Schedule, providers focus group     
  
As you know, I am doing this research to try and understand what worked and what didn’t 
work in the IPV pilot project, and how we can improve the process in the future or in other 
places. I am interested in your experiences and your thoughts and feelings about the 
project. 
How did you find this intervention? 
Prompts: 
 Benefits 
What challenges did you have working with this intervention? 
Prompts: 
 Patients don’t want to talk 
 Time 
 Difficult to ask 
 Upsetting 
 New projects 
Do you think there is a need for something like this? 
Prompts: 
 Burden of disease 
 Need in health services 
 Need in this area 
Did you think this intervention meets this need? In what ways? 
Prompts: 
 Unmet need 
How well do you think the intervention fitted into the system? 
  10 
 
How could it have been better? 
Do you feel you have the skills needed to provide this intervention? 
Prompts: 
 Counseling 
 Mental health 
 What other skills needed? 
Did you get enough training? 
 Usefulness of the training 
 Knowledge of IPV 
 How to manage 
Did you feel that you had the support you needed to provide the intervention? 
Prompts: 
 Driver of the project 
 Questions or problems 
 What else could have been done 
 Support for integrating new projects 
What role do you think a doctor or nurse should play in IPV? 
Prompts: 
 Treating injuries 
 Forensics 
 Counselling/advice 
 Referral 
What role do you think the health services should play in IPV? 
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Prompts: 
 Screening 
 Managing patients 
 Prevention 
 
 
 
 
 
 
 
 
 
  12 
 
Appendix D: Discussion schedule, user interview 
 
As you know, I am doing this research to find out how useful you and others found this 
service and how we can improve it in future. 
To start with, can you tell me how you came to know about this service? 
Prompts: 
 Referred from where? 
If appropriate: How did you feel when asked about this problem by your doctor or nurse? 
Have you ever looked for help for this problem before? 
Prompts: 
 From clinic 
 From police 
 From elsewhere 
If yes, tell me about those experiences… 
What did you expect when you made your appointment?   
When you came to your appointment how did you feel it went? 
Did you feel there were any parts of the service that were particularly helpful? 
Prompts: 
 Legal 
 Talking about it/assessment 
 Referrals 
Did you feel there was anything that wasn’t helpful? 
Did anything change for you because of the service? 
Was there anything that you thought was harmful or made things worse for you? 
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Prompts: 
 Partner or someone else finding out 
 Fear of someone finding out 
 Being distressed 
What could have been done differently to help you? 
How did you find the clinic as the setting of the interview? 
Would you recommend someone else in your position should come for this service? 
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Appendix E: Discussion schedule, users who have not been through the service 
 
As you know, I am doing this research to find out how we can improve this service so that 
more women like yourself could benefit from it in the future.   
First, I’d like to know if you have ever been asked about this problem by your doctor or 
nurse. 
If you have, how did you feel when that happened? If not, do you want your doctor or 
nurse to ask you about this problem? 
Have you ever looked for help for this problem before? 
Prompts: 
 From clinic 
 From police 
 From elsewhere 
If yes, tell me about those experiences… 
When you heard about this service, what did you think it would be about? 
Prompts: 
 What were you told? 
Do you feel that you need help for this problem? 
Do you want to get help for this problem at the clinic? 
What made you decide this service was not for you? 
Prompts: 
 Don’t need help 
 Distance from clinic 
 Childcare/job 
 Fear of partner finding out 
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 Staff attitude 
What kind of things would be helpful to you? 
Prompts: 
 Counseling 
 Listening and support 
 Legal services 
 Help with work/grant/children 
 HIV test 
 Pregnancy test 
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Appendix F: Informed consent, interviews  
 
Informed Consent Form for Participation in Research Study: Evaluating the 
implementation of an intervention for intimate partner violence in the district health 
system of the Western Cape 
 UNIVERSITY OF CAPE TOWN 
Principal Investigator: Dr Kate Rees, University of Cape Town 
0214839344 
kate.rees@westerncape.gov.za 
Reference Number: ___________________________ 
You are invited to participate in the study: Evaluating the implementation of an intervention 
for intimate partner violence in the district health system of the Western Cape  
Why is this study being done? 
My name is Kate Rees; I am a medical doctor and graduate student in Public Health 
conducting research as part of my training. I am also conducting an evaluation of an 
intervention for intimate partner violence as part of my work for the Western Cape 
Government Department of Health. 
The purpose of the study is to understand the implementation of this intervention, and how 
providers and users experienced the intervention in order to improve it in the future. 
What do I have to do if I participate in this study? 
 If you choose to participate in this study you will be asked questions in an interview 
lasting approximately one hour.  
 This interview will take place in a private place that is convenient for you.  
 The interview will be recorded with your permission.  
 The questions that will be asked are about your experiences of the IPV intervention.   
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What are the consequences of not participating? 
There will be no negative consequences if you choose not to participate. Participation is 
completely voluntary. 
What are the possible risks? 
The risks that may be expected as a result of the study include experiencing distress or 
discomfort in being asked questions you may find sensitive. You do not have to answer all 
the questions, and may skip a question or end the interview at any time. 
What are the potential benefits? 
There will be no direct benefit to you in participating in this study. However, the 
information gained in this study will be disseminated in an attempt to ensure that the 
design of future interventions for IPV consider the information gained from this research.   
How will confidentiality be maintained? 
All information you share will be kept completely confidential. Your name will not appear 
anywhere on the interview transcript, or in any analysis or report. All electronic records will 
be password protected, and audio recordings will be destroyed on completion of the 
project.  
 
Informed Consent to Participate in the Study 
I have had all of the above information explained to me and I understand the explanation. I 
have been offered the chance to ask any questions. 
Name        Date 
___________________________                                                   
__________________________      
Signature 
___________________________ 
 
Informed Consent to audio record the interview 
The purpose and handling of the audio recording has been explained to me and I 
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understand this explanation.  
Name        Date 
___________________________                                                   
__________________________      
Signature 
___________________________ 
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Appendix G: Informed consent, focus groups  
 
Informed Consent Form for Participation in Research Study: Evaluating the 
implementation of an intervention for intimate partner violence in the district health 
system of the Western Cape 
 UNIVERSITY OF CAPE TOWN 
Principal Investigator: Dr Kate Rees, University of Cape Town 
0214839344 
kate.rees@westerncape.gov.za 
Reference Number: ___________________________ 
You are invited to participate in the study: Evaluating the implementation of an intervention 
for intimate partner violence in the district health system of the Western Cape  
Why is this study being done? 
My name is Kate Rees; I am a medical doctor and graduate student in Public Health 
conducting research as part of my training. I am also conducting an evaluation of an 
intervention for intimate partner violence as part of my work for the Western Cape 
Government Department of Health. 
The purpose of the study is to understand the implementation of this intervention, and how 
providers and users experienced the intervention in order to improve it in the future. 
What do I have to do if I participate in this study? 
 If you choose to participate in this study you will be asked questions in a group last-
ing approximately one hour.  
 The group will be asked to keep everything discussed confidential.  
 The group will be recorded with your permission.  
 The questions that will be asked are about your experiences of the IPV intervention.   
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What are the consequences of not participating? 
There will be no negative consequences if you choose not to participate. Participation is 
completely voluntary. 
What are the possible risks? 
The risks that may be expected as a result of the study include experiencing distress or 
discomfort in being asked questions you may find sensitive. You do not have to answer all 
the questions, and may skip a question or end the interview at any time. 
What are the potential benefits? 
There will be no direct benefit to you in participating in this study. However, the 
information gained in this study will be disseminated in an attempt to ensure that the 
design of future interventions for IPV consider the information gained from this research.   
How will confidentiality be maintained? 
All information you share will be kept completely confidential. Your name will not appear 
anywhere on the interview transcript, or in any analysis or report. All electronic records will 
be password protected, and audio recordings will be destroyed on completion of the 
project.  
 
Informed Consent to Participate in the Study 
I have had all of the above information explained to me and I understand the explanation. I 
have been offered the chance to ask any questions. 
Name        Date 
___________________________                                                   
__________________________      
Signature 
___________________________ 
 
Informed Consent to audio record the interview 
The purpose and handling of the audio recording has been explained to me and I 
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understand this explanation.  
Name        Date 
___________________________                                                   
__________________________      
Signature 
___________________________ 
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Appendix H: Informed consent, service provider interviews  
 
Informed Consent Form for Participation in Research Study: Evaluating the implementa-
tion of an intervention for intimate partner violence in the district health system of the 
Western Cape 
 UNIVERSITY OF CAPE TOWN 
Principal Investigator: Dr Kate Rees, University of Cape Town 
0214839344 
kate.rees@westerncape.gov.za 
Reference Number: ___________________________ 
You are invited to participate in the study: Evaluating the implementation of an interven-
tion for intimate partner violence in the district health system of the Western Cape  
Why is this study being done? 
My name is Kate Rees; I am a medical doctor and graduate student in Public Health con-
ducting research as part of my training. I am also conducting an evaluation of an interven-
tion for intimate partner violence as part of my work for the Western Cape Government 
Department of Health. 
The purpose of the study is to understand the implementation of this intervention, and 
how providers and users experienced the intervention in order to improve it in the future. 
What do I have to do if I participate in this study? 
 If you choose to participate in this study you will be asked questions in an interview 
lasting approximately one hour.  
 This interview will take place in a private place that is convenient for you.  
 The interview will be recorded with your permission.  
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 The questions that will be asked are about your experiences of the IPV interven-
tion.   
What are the consequences of not participating? 
There will be no negative consequences if you choose not to participate. Participation is 
completely voluntary. 
What are the possible risks? 
The risks that may be expected as a result of the study include experiencing distress or dis-
comfort in being asked questions you may find sensitive. You do not have to answer all the 
questions, and may skip a question or end the interview at any time. 
What are the potential benefits? 
There will be no direct benefit to you in participating in this study. However, the infor-
mation gained in this study will be disseminated in an attempt to ensure that the design of 
future interventions for IPV consider the information gained from this research.   
How will confidentiality be maintained? 
All information you share will be kept completely confidential. Your name will not appear 
anywhere on the interview transcript, or in any analysis or report. All electronic records will 
be password protected, and audio recordings will be destroyed on completion of the pro-
ject. There is a possibility that people closely acquainted with the project will be able to 
identify you when reading the report based on your role within this project. Every effort 
will be made to avoid this. 
 
Informed Consent to Participate in the Study 
I have had all of the above information explained to me and I understand the explanation. I 
have been offered the chance to ask any questions. 
Name        Date 
___________________________                                                   
__________________________      
Signature 
___________________________ 
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Informed Consent to audio record the interview 
The purpose and handling of the audio recording has been explained to me and I under-
stand this explanation.  
Name        Date 
___________________________                                                   
__________________________      
Signature 
___________________________ 
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Appendix I: Ethics approval letter  
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Appendix J: Department of Health approval letter  
 
  27 
 
Appendix K: BMC Health Services Research author guidelines  
http://www.biomedcentral.com/bmchealthservres/authors/instructions/researchar
ticle 
Accessed 26/03/2014 
Instructions for authors 
Research articles 
Criteria | Submission process | Preparing main manuscript text | Preparing illustrations and 
figures |Preparing tables | Preparing additional files | Style and language 
Assistance with the process of manuscript preparation and submission is available 
from BioMed Central customer support team. See 'About this journal' for information about 
policies and the refereeing process. We also provide a collection of links to useful tools and 
resources for scientific authors on our page. 
Criteria 
Research articles should report on original primary research, but may report on systematic 
reviews of published research provided they adhere to the appropriate reporting guidelines 
which are detailed in our Editorial Policies. Please note that non-commissioned pooled 
analyses of selected published research will not be considered. 
Submission process 
Manuscripts must be submitted by one of the authors of the manuscript, and should not be 
submitted by anyone on their behalf. The submitting author takes responsibility for the 
article during submission and peer review. 
Please note that BMC Health Services Research levies an article-processing charge on all 
accepted Research articles; if the submitting author's institution is a BioMed Central 
member the cost of the article-processing charge may be covered by the membership 
(see About page for detail). Please note that the membership is only automatically 
recognised on submission if the submitting author is based at the member institution. 
To facilitate rapid publication and to minimize administrative costs, BMC Health Services 
Researchprefers online submission. 
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Files can be submitted as a batch, or one by one. The submission process can be 
interrupted at any time; when users return to the site, they can carry on where they left off. 
See below for examples of word processor and graphics file formats that can be accepted 
for the main manuscript document by the online submission system. Additional files of any 
type, such asmovies, animations, or original data files, can also be submitted as part of the 
manuscript. 
During submission you will be asked to provide a cover letter. Use this to explain why your 
manuscript should be published in the journal, to elaborate on any issues relating to our 
editorial policies in the 'About BMC Health Services Research' page, and to declare any 
potential competing interests. You will be also asked to provide the contact details 
(including email addresses) of potential peer reviewers for your manuscript. These should 
be experts in their field, who will be able to provide an objective assessment of the 
manuscript. Any suggested peer reviewers should not have published with any of the 
authors of the manuscript within the past five years, should not be current collaborators, 
and should not be members of the same research institution. Suggested reviewers will be 
considered alongside potential reviewers recommended by the Editorial team, Editorial 
Advisors, Section Editors and Associate Editors. 
Assistance with the process of manuscript preparation and submission is available 
from BioMed Central customer support team. 
We also provide a collection of links to useful tools and resources for scientific authors on 
our Useful Tools page. 
File formats 
The following word processor file formats are acceptable for the main manuscript 
document: 
 Microsoft word (DOC, DOCX) 
 Rich text format (RTF) 
 Portable document format (PDF) 
 TeX/LaTeX (use BioMed Central's TeX template) 
 DeVice Independent format (DVI) 
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TeX/LaTeX users: Please use BioMed Central's TeX template and BibTeX stylefile if you use 
TeX format. During the TeX submission process, please submit your TeX file as the main 
manuscript file and your bib/bbl file as a dependent file. Please also convert your TeX file 
into a PDF and submit this PDF as an additional file with the name 'Reference PDF'. This PDF 
will be used by internal staff as a reference point to check the layout of the article as the 
author intended. Please also note that all figures must be coded at the end of the TeX file 
and not inline. 
If you have used another template for your manuscript, or if you do not wish to use BibTeX, 
then please submit your manuscript as a DVI file. We do not recommend converting to RTF. 
For all TeX submissions, all relevant editable source must be submitted during the 
submission process. Failing to submit these source files will cause unnecessary delays in the 
publication procedures. 
Publishing Datasets 
Through a special arrangement with LabArchives, LLC, authors submitting manuscripts to 
BMC Health Services Research can obtain a complimentary subscription to LabArchives with 
an allotment of 100MB of storage. LabArchives is an Electronic Laboratory Notebook which 
will enable scientists to share and publish data files in situ; you can then link your paper to 
these data. Data files linked to published articles are assigned digital object identifiers 
(DOIs) and will remain available in perpetuity. Use of LabArchives or similar data publishing 
services does not replace preexisting data deposition requirements, such as for nucleic acid 
sequences, protein sequences and atomic coordinates. 
Instructions on assigning DOIs to datasets, so they can be permanently linked to 
publications, can be found on the LabArchives website. Use of LabArchives’ software has no 
influence on the editorial decision to accept or reject a manuscript. 
Authors linking datasets to their publications should include an Availability of supporting 
data section in their manuscript and cite the dataset in their reference list. 
Preparing main manuscript text 
General guidelines of the journal's style and language are given below. 
Overview of manuscript sections for Research articles 
Manuscripts for Research articles submitted to BMC Health Services Research should be 
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divided into the following sections (in this order): 
 Title page 
 Abstract 
 Keywords 
 Background 
 Methods 
 Results and discussion 
 Conclusions 
 List of abbreviations used (if any) 
 Competing interests 
 Authors' contributions 
 Authors' information 
 Acknowledgements 
 Endnotes 
 References 
 Illustrations and figures (if any) 
 Tables and captions 
 Preparing additional files 
The Accession Numbers of any nucleic acid sequences, protein sequences or atomic 
coordinates cited in the manuscript should be provided, in square brackets and include the 
corresponding database name; for example, [EMBL:AB026295, EMBL:AC137000, 
DDBJ:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116]. 
The databases for which we can provide direct links are: EMBL Nucleotide Sequence 
Database (EMBL), DNA Data Bank of Japan (DDBJ), GenBank at the NCBI (GenBank), Protein 
Data Bank (PDB), Protein Information Resource (PIR) and the Swiss-Prot Protein Database 
(Swiss-Prot). 
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You can download a template (Mac and Windows compatible; Microsoft Word 98/2000) for 
your article. 
For reporting standards please see the information in the About section. 
Title page 
The title page should: 
 provide the title of the article 
 list the full names, institutional addresses and email addresses for all authors 
 indicate the corresponding author 
Please note: 
 the title should include the study design, for example "A versus B in the treatment 
of C: a randomized controlled trial X is a risk factor for Y: a case control study" 
 abbreviations within the title should be avoided 
Abstract 
The Abstract of the manuscript should not exceed 350 words and must be structured into 
separate sections: Background, the context and purpose of the study; Methods, how the 
study was performed and statistical tests used; Results, the main findings; Conclusions, 
brief summary and potential implications. Please minimize the use of abbreviations and do 
not cite references in the abstract. Trial registration, if your research article reports the 
results of a controlled health care intervention, please list your trial registry, along with the 
unique identifying number (e.g. Trial registration: Current Controlled Trials 
ISRCTN73824458). Please note that there should be no space between the letters and 
numbers of your trial registration number. We recommend manuscripts that report 
randomized controlled trials follow the CONSORT extension for abstracts. 
Keywords 
Three to ten keywords representing the main content of the article. 
Background 
The Background section should be written in a way that is accessible to researchers without 
  32 
 
specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the 
background to the research and its aims. Reports of clinical research should, where 
appropriate, include a summary of a search of the literature to indicate why this study was 
necessary and what it aimed to contribute to the field. The section should end with a brief 
statement of what is being reported in the article. 
Methods 
The methods section should include the design of the study, the setting, the type of 
participants or materials involved, a clear description of all interventions and comparisons, 
and the type of analysis used, including a power calculation if appropriate. Generic drug 
names should generally be used. When proprietary brands are used in research, include the 
brand names in parentheses in the Methods section. 
For studies involving human participants a statement detailing ethical approval and consent 
should be included in the methods section. For further details of the journal's editorial 
policies and ethical guidelines see 'About this journal'. 
For further details of the journal's data-release policy, see the policy section in 'About this 
journal'. 
Results and discussion 
The Results and discussion may be combined into a single section or presented separately. 
Results of statistical analysis should include, where appropriate, relative and absolute risks 
or risk reductions, and confidence intervals. The Results and discussion sections may also 
be broken into subsections with short, informative headings. 
Conclusions 
This should state clearly the main conclusions of the research and give a clear explanation 
of their importance and relevance. Summary illustrations may be included. 
List of abbreviations 
If abbreviations are used in the text they should be defined in the text at first use, and a list 
of abbreviations can be provided, which should precede the competing interests and 
authors' contributions. 
Competing interests 
  33 
 
A competing interest exists when your interpretation of data or presentation of information 
may be influenced by your personal or financial relationship with other people or 
organizations. Authors must disclose any financial competing interests; they should also 
reveal any non-financial competing interests that may cause them embarrassment were 
they to become public after the publication of the manuscript. 
Authors are required to complete a declaration of competing interests. All competing 
interests that are declared will be listed at the end of published articles. Where an author 
gives no competing interests, the listing will read 'The author(s) declare that they have no 
competing interests'. 
When completing your declaration, please consider the following questions: 
Financial competing interests 
 In the past five years have you received reimbursements, fees, funding, or salary 
from an organization that may in any way gain or lose financially from the publica-
tion of this manuscript, either now or in the future? Is such an organization financ-
ing this manuscript (including the article-processing charge)? If so, please specify. 
 Do you hold any stocks or shares in an organization that may in any way gain or lose 
financially from the publication of this manuscript, either now or in the future? If 
so, please specify. 
 Do you hold or are you currently applying for any patents relating to the content of 
the manuscript? Have you received reimbursements, fees, funding, or salary from 
an organization that holds or has applied for patents relating to the content of the 
manuscript? If so, please specify. 
 Do you have any other financial competing interests? If so, please specify. 
Non-financial competing interests 
Are there any non-financial competing interests (political, personal, religious, ideological, 
academic, intellectual, commercial or any other) to declare in relation to this manuscript? If 
so, please specify. 
If you are unsure as to whether you, or one your co-authors, has a competing interest 
please discuss it with the editorial office. 
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Authors' contributions 
In order to give appropriate credit to each author of a paper, the individual contributions of 
authors to the manuscript should be specified in this section. 
According to ICMJE guidelines, An 'author' is generally considered to be someone who has 
made substantive intellectual contributions to a published study. To qualify as an author 
one should 1) have made substantial contributions to conception and design, or acquisition 
of data, or analysis and interpretation of data; 2) have been involved in drafting the 
manuscript or revising it critically for important intellectual content; 3) have given final 
approval of the version to be published; and 4) agree to be accountable for all aspects of 
the work in ensuring that questions related to the accuracy or integrity of any part of the 
work are appropriately investigated and resolved. Each author should have participated 
sufficiently in the work to take public responsibility for appropriate portions of the content. 
Acquisition of funding, collection of data, or general supervision of the research group, 
alone, does not justify authorship. 
We suggest the following kind of format (please use initials to refer to each author's 
contribution): AB carried out the molecular genetic studies, participated in the sequence 
alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in 
the sequence alignment. ES participated in the design of the study and performed the 
statistical analysis. FG conceived of the study, and participated in its design and 
coordination and helped to draft the manuscript. All authors read and approved the final 
manuscript. 
All contributors who do not meet the criteria for authorship should be listed in an 
acknowledgements section. Examples of those who might be acknowledged include a 
person who provided purely technical help, writing assistance, or a department chair who 
provided only general support. 
Authors' information 
You may choose to use this section to include any relevant information about the author(s) 
that may aid the reader's interpretation of the article, and understand the standpoint of the 
author(s). This may include details about the authors' qualifications, current positions they 
hold at institutions or societies, or any other relevant background information. Please refer 
to authors using their initials. Note this section should not be used to describe any 
competing interests. 
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Please acknowledge anyone who contributed towards the article by making substantial 
contributions to conception, design, acquisition of data, or analysis and interpretation of 
data, or who was involved in drafting the manuscript or revising it critically for important 
intellectual content, but who does not meet the criteria for authorship. Please also include 
the source(s) of funding for each author, and for the manuscript preparation. Authors must 
describe the role of the funding body, if any, in design, in the collection, analysis, and 
interpretation of data; in the writing of the manuscript; and in the decision to submit the 
manuscript for publication. Please also acknowledge anyone who contributed materials 
essential for the study. If a language editor has made significant revision of the manuscript, 
we recommend that you acknowledge the editor by name, where possible. 
The role of a scientific (medical) writer must be included in the acknowledgements section, 
including their source(s) of funding. We suggest wording such as 'We thank Jane Doe who 
provided medical writing services on behalf of XYZ Pharmaceuticals Ltd.' 
Authors should obtain permission to acknowledge from all those mentioned in the 
Acknowledgements section. 
Endnotes 
Endnotes should be designated within the text using a superscript lowercase letter and all 
notes (along with their corresponding letter) should be included in the Endnotes section. 
Please format this section in a paragraph rather than a list. 
References 
All references, including URLs, must be numbered consecutively, in square brackets, in the 
order in which they are cited in the text, followed by any in tables or legends. Each 
reference must have an individual reference number. Please avoid excessive referencing. If 
automatic numbering systems are used, the reference numbers must be finalized and the 
bibliography must be fully formatted before submission. 
Only articles, datasets, clinical trial registration records and abstracts that have been 
published or are in press, or are available through public e-print/preprint servers, may be 
cited; unpublished abstracts, unpublished data and personal communications should not be 
included in the reference list, but may be included in the text and referred to as 
"unpublished observations" or "personal communications" giving the names of the involved 
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researchers. Obtaining permission to quote personal communications and unpublished data 
from the cited colleagues is the responsibility of the author. Footnotes are not allowed, but 
endnotes are permitted. Journal abbreviations follow Index Medicus/MEDLINE. Citations in 
the reference list should include all named authors, up to the first 30 before adding 'et al.'.. 
Any in press articles cited within the references and necessary for the reviewers' 
assessment of the manuscript should be made available if requested by the editorial office. 
Style files are available for use with popular bibliographic management software: 
 BibTeX 
 EndNote style file 
 Reference Manager 
 Zotero 
Examples of the BMC Health Services Research reference style are shown below. Please 
ensure that the reference style is followed precisely; if the references are not in the correct 
style they may have to be retyped and carefully proofread. 
All web links and URLs, including links to the authors' own websites, should be given a 
reference number and included in the reference list rather than within the text of the 
manuscript. They should be provided in full, including both the title of the site and the URL, 
in the following format: The Mouse Tumor Biology 
Database [http://tumor.informatics.jax.org/mtbwi/index.do]. If an author or group of 
authors can clearly be associated with a web link, such as for weblogs, then they should be 
included in the reference. 
Examples of the BMC Health Services Research reference style 
 
Article within a journal 
Koonin EV, Altschul SF, Bork P: BRCA1 protein products: functional motifs. Nat 
Genet 1996,13:266-267. 
Article within a journal supplement 
Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab initio 
three-dimensional prediction, secondary structure, and contacts 
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prediction. Proteins 1999,43(Suppl 3):149-170. 
In press article 
Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press. 
Published abstract 
Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN: Mesenchymal cells, 
stromal derived factor-1 and rheumatoid arthritis [abstract]. Arthritis 
Rheum 1999, 42:s250. 
Article within conference proceedings 
Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National 
Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: 
Butterworth-Heinemann; 1996:16-27. 
Book chapter, or article within a book 
Schnepf E: From prey via endosymbiont to plastids: comparative studies in 
dinoflagellates. In Origins of Plastids. Volume 2. 2nd edition. Edited by Lewin RA. New York: 
Chapman and Hall; 1993:53-76. 
Whole issue of journal 
Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast Cancer 
Res 1998, 10:1-72. 
Whole conference proceedings 
Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 27-30 June 
1996; Baltimore. Stoneham: Butterworth-Heinemann; 1996. 
Complete book 
Margulis L: Origin of Eukaryotic Cells. New Haven: Yale University Press; 1970. 
Monograph or book in a series 
Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured Human Cells and 
Tissues.Edited by Harris TJR. New York: Academic Press; 1995:54-56. [Stoner G (Series 
Editor): Methods and Perspectives in Cell Biology, vol 1.] 
Book with institutional author 
Advisory Committee on Genetic Modification: Annual Report. London; 1999. 
PhD thesis 
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Kohavi R: Wrappers for performance enhancement and oblivious decision graphs. PhD 
thesis. Stanford University, Computer Science Department; 1995. 
Link / URL 
The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do] 
Link / URL with author(s) 
Corpas M: The Crowdfunding Genome Project: a personal genomics community with 
open source values [http://blogs.biomedcentral.com/bmcblog/2012/07/16/the-
crowdfunding-genome-project-a-personal-genomics-community-with-open-source-values/] 
Dataset with persistent identifier 
Zheng, L-Y; Guo, X-S; He, B; Sun, L-J; Peng, Y; Dong, S-S; Liu, T-F; Jiang, S; Ramachandran, S; 
Liu, C-M; Jing, H-C (2011): Genome data from sweet and grain sorghum (Sorghum 
bicolor).GigaScience. http://dx.doi.org/10.5524/100012. 
Clinical trial registration record with persistent identifier 
Mendelow, AD (2006): Surgical Trial in Lobar Intracerebral Haemorrhage. Current 
Controlled Trials. http://dx.doi.org/10.1186/ISRCTN22153967 
Preparing illustrations and figures 
Illustrations should be provided as separate files, not embedded in the text file. Each figure 
should include a single illustration and should fit on a single page in portrait format. If a 
figure consists of separate parts, it is important that a single composite illustration file be 
submitted which contains all parts of the figure. There is no charge for the use of color 
figures. 
Please read our figure preparation guidelines for detailed instructions on maximising the 
quality of your figures. 
Formats 
The following file formats can be accepted: 
 PDF (preferred format for diagrams) 
 DOCX/DOC (single page only) 
 PPTX/PPT (single slide only) 
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 EPS 
 PNG (preferred format for photos or images) 
 TIFF 
 JPEG 
 BMP 
Figure legends 
The legends should be included in the main manuscript text file at the end of the 
document, rather than being a part of the figure file. For each figure, the following 
information should be provided: Figure number (in sequence, using Arabic numerals - i.e. 
Figure 1, 2, 3 etc); short title of figure (maximum 15 words); detailed legend, up to 300 
words. 
Please note that it is the responsibility of the author(s) to obtain permission from the 
copyright holder to reproduce figures or tables that have previously been published 
elsewhere. 
Preparing tables 
Each table should be numbered and cited in sequence using Arabic numerals (i.e. Table 1, 2, 
3 etc.). Tables should also have a title (above the table) that summarizes the whole table; it 
should be no longer than 15 words. Detailed legends may then follow, but they should be 
concise. Tables should always be cited in text in consecutive numerical order. 
Smaller tables considered to be integral to the manuscript can be pasted into the end of the 
document text file, in A4 portrait or landscape format. These will be typeset and displayed 
in the final published form of the article. Such tables should be formatted using the 'Table 
object' in a word processing program to ensure that columns of data are kept aligned when 
the file is sent electronically for review; this will not always be the case if columns are 
generated by simply using tabs to separate text. Columns and rows of data should be made 
visibly distinct by ensuring that the borders of each cell display as black lines. Commas 
should not be used to indicate numerical values. Color and shading may not be used; parts 
of the table can be highlighted using symbols or bold text, the meaning of which should be 
explained in a table legend. Tables should not be embedded as figures or spreadsheet files. 
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Larger datasets or tables too wide for a portrait page can be uploaded separately as 
additional files. Additional files will not be displayed in the final, laid-out PDF of the article, 
but a link will be provided to the files as supplied by the author. 
Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls ) or 
comma separated values (.csv). As with all files, please use the standard file extensions. 
Preparing additional files 
Although BMC Health Services Research does not restrict the length and quantity of data 
included in an article, we encourage authors to provide datasets, tables, movies, or other 
information as additional files. 
Please note: All Additional files will be published along with the article. Do not include files 
such as patient consent forms, certificates of language editing, or revised versions of the 
main manuscript document with tracked changes. Such files should be sent by email 
to editorial@biomedcentral.com, quoting the Manuscript ID number. 
Results that would otherwise be indicated as "data not shown" can and should be included 
as additional files. Since many weblinks and URLs rapidly become broken, BMC Health 
Services Research requires that supporting data are included as additional files, or 
deposited in a recognized repository. Please do not link to data on a personal/departmental 
website. The maximum file size for additional files is 20 MB each, and files will be virus-
scanned on submission. 
Additional files can be in any format, and will be downloadable from the final published 
article as supplied by the author. We recommend CSV rather than PDF for tabular data. 
Certain supported files formats are recognized and can be displayed to the user in the 
browser. These include most movie formats (for users with the Quicktime plugin), mini-
websites prepared according to our guidelines, chemical structure files (MOL, PDB), 
geographic data files (KML). 
If additional material is provided, please list the following information in a separate section 
of the manuscript text: 
 File name (e.g. Additional file 1) 
 File format including the correct file extension for example .pdf, .xls, .txt, .pptx (in-
cluding name and a URL of an appropriate viewer if format is unusual) 
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 Title of data 
 Description of data 
Additional files should be named "Additional file 1" and so on and should be referenced 
explicitly by file name within the body of the article, e.g. 'An additional movie file shows 
this in more detail [see Additional file 1]'. 
Additional file formats 
Ideally, file formats for additional files should not be platform-specific, and should be 
viewable using free or widely available tools. The following are examples of suitable 
formats. 
 Additional documentation 
o PDF (Adode Acrobat) 
 Animations 
o SWF (Shockwave Flash) 
 Movies 
o MP4 (MPEG 4) 
o MOV (Quicktime) 
 Tabular data 
o XLS, XLSX (Excel Spreadsheet) 
o CSV (Comma separated values) 
As with figure files, files should be given the standard file extensions. 
Mini-websites 
Small self-contained websites can be submitted as additional files, in such a way that they 
will be browsable from within the full text HTML version of the article. In order to do this, 
please follow these instructions: 
1. Create a folder containing a starting file called index.html (or index.htm) in the root. 
2. Put all files necessary for viewing the mini-website within the folder, or sub-folders. 
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3. Ensure that all links are relative (ie "images/picture.jpg" rather than 
"/images/picture.jpg" or "http://yourdomain.net/images/picture.jpg" or 
"C:\Documents and Settings\username\My Documents\mini-
website\images\picture.jpg") and no link is longer than 255 characters. 
4. Access the index.html file and browse around the mini-website, to ensure that the 
most commonly used browsers (Internet Explorer and Firefox) are able to view all 
parts of the mini-website without problems, it is ideal to check this on a different 
machine. 
5. Compress the folder into a ZIP, check the file size is under 20 MB, ensure that in-
dex.html is in the root of the ZIP, and that the file has .zip extension, then submit as 
an additional file with your article. 
Style and language 
General 
Currently, BMC Health Services Research can only accept manuscripts written in English. 
Spelling should be US English or British English, but not a mixture. 
There is no explicit limit on the length of articles submitted, but authors are encouraged to 
be concise. 
BMC Health Services Research will not edit submitted manuscripts for style or language; 
reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. 
Authors are advised to write clearly and simply, and to have their article checked by 
colleagues before submission. In-house copyediting will be minimal. Non-native speakers of 
English may choose to make use of a copyediting service. 
Language editing 
For authors who wish to have the language in their manuscript edited by a native-English 
speaker with scientific expertise, BioMed Central recommends Edanz. BioMed Central has 
arranged a 10% discount to the fee charged to BioMed Central authors by Edanz. Use of an 
editing service is neither a requirement nor a guarantee of acceptance for publication. 
Please contact Edanz directly to make arrangements for editing, and for pricing and 
payment details. 
Help and advice on scientific writing 
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The abstract is one of the most important parts of a manuscript. For guidance, please visit 
our page on Writing titles and abstracts for scientific articles. 
Tim Albert has produced for BioMed Central a list of tips for writing a scientific 
manuscript. American Scientist also provides a list of resources for science writing. For 
more detailed guidance on preparing a manuscript and writing in English, please visit 
the BioMed Central author academy. 
Abbreviations 
Abbreviations should be used as sparingly as possible. They should be defined when first 
used and a list of abbreviations can be provided following the main manuscript text. 
Typography 
 Please use double line spacing. 
 Type the text unjustified, without hyphenating words at line breaks. 
 Use hard returns only to end headings and paragraphs, not to rearrange lines. 
 Capitalize only the first word, and proper nouns, in the title. 
 All lines and pages should be numbered. Authors are asked to ensure that line 
numbering is included in the main text file of their manuscript at the time of sub-
mission to facilitate peer-review. Once a manuscript has been accepted, line num-
bering should be removed from the manuscript before publication. For authors 
submitting their manuscript in Microsoft Word please do not insert page breaks in 
your manuscript to ensure page numbering is consistent between your text file and 
the PDF generated from your submission and used in the review process. 
 Use the BMC Health Services Research reference format. 
 Footnotes are not allowed, but endnotes are permitted. 
 Please do not format the text in multiple columns. 
 Greek and other special characters may be included. If you are unable to reproduce 
a particular special character, please type out the name of the symbol in full. Please 
ensure that all special characters used are embedded in the text, otherwise they 
will be lost during conversion to PDF. 
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Units 
SI units should be used throughout (liter and molar are permitted, however). 
 
 
